| 1 |
Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
|
| 2 |
Bleomycin FDA Label
|
| 3 |
Gemcitabine FDA Label
|
| 4 |
Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
|
| 5 |
FDA Approved Drug Products from FDA Official Website. 2021. Application Number: 761208.
|
| 6 |
Topotecan FDA Label
|
| 7 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 8 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 9 |
ClinicalTrials.gov (NCT04943627) A Phase 3 Trial of Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer After Platinum-Based Chemotherapy (BRAVA). U.S.National Institutes of Health.
|
| 10 |
Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models. Mol Clin Oncol. 2014 Nov;2(6):935-944.
|
| 11 |
ClinicalTrials.gov (NCT04693234) AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Previously Treated Recurrent or Metastatic Cervical Cancer. U.S. National Institutes of Health.
|
| 12 |
ClinicalTrials.gov (NCT00264732) A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix. U.S. National Institutes of Health.
|
| 13 |
ClinicalTrials.gov (NCT02002182) Window of Opportunity Trial of ADXS 11-001 Vaccination Prior to Robotic Surgery of HPV-Positive Oropharyngeal Cancer. U.S. National Institutes of Health.
|
| 14 |
Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.J Med Chem. 2019 Feb 28;62(4):1715-1730.
|
| 15 |
ClinicalTrials.gov (NCT04380805) A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer. U.S. National Institutes of Health.
|
| 16 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027982)
|
| 17 |
Clinical pipeline report, company report or official report of Nanotherapeutics.
|
| 18 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008671)
|
| 19 |
ClinicalTrials.gov (NCT00520598) Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001). U.S. National Institutes of Health.
|
| 20 |
ClinicalTrials.gov (NCT01583686) CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
|
| 21 |
ClinicalTrials.gov (NCT03356795) Intervention of CAR-T Against Cervical Cancer
|
| 22 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 23 |
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer. Oncotarget. 2015 Oct 13;6(31):32228-43.
|
| 24 |
ClinicalTrials.gov (NCT05033132) An Open-label, Multicenter Phase II Study Evaluating Balstilimab Alone or Balstilimab in Combination With Zalifrelimab in Patients With Advanced Cervical Cancer. U.S.National Institutes of Health.
|
| 25 |
Clinical pipeline report, company report or official report of Inovio Pharmaceuticals.
|
| 26 |
ClinicalTrials.gov (NCT01880411) Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine. U.S. National Institutes of Health.
|
| 27 |
ClinicalTrials.gov (NCT00788164) Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia. U.S. National Institutes of Health.
|
| 28 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011302)
|
| 29 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 30 |
Deletion of chromosome 3p is an early event in malignant progression of cervical cancer.Anticancer Res. 1998 Mar-Apr;18(2A):707-12.
|
| 31 |
Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.Biochem J. 2007 May 1;403(3):501-10. doi: 10.1042/BJ20061053.
|
| 32 |
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.Gynecol Oncol. 2015 Dec;139(3):529-35. doi: 10.1016/j.ygyno.2015.09.087. Epub 2015 Oct 4.
|
| 33 |
Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.J Enzyme Inhib Med Chem. 2018 Dec;33(1):1137-1149. doi: 10.1080/14756366.2018.1481403.
|
| 34 |
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.Genes Chromosomes Cancer. 2007 Apr;46(4):373-84. doi: 10.1002/gcc.20418.
|
| 35 |
HPV-16-related proteins as the serologic markers in cervical neoplasia.Gynecol Oncol. 1998 Apr;69(1):47-55. doi: 10.1006/gyno.1998.4963.
|
| 36 |
Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array.Clin Cancer Res. 1998 Dec;4(12):3045-50.
|
| 37 |
Targeting of -Catenin Reverses Radioresistance of Cervical Cancer with the PIK3CA-E545K Mutation.Mol Cancer Ther. 2020 Feb;19(2):337-347. doi: 10.1158/1535-7163.MCT-19-0309. Epub 2019 Oct 30.
|
| 38 |
Up-regulation of 5-lipoxygenase by inhibition of cathepsin G enhances TRAIL-induced apoptosis through down-regulation of survivin.Oncotarget. 2017 Nov 20;8(63):106672-106684. doi: 10.18632/oncotarget.22508. eCollection 2017 Dec 5.
|
| 39 |
Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.Int J Cancer. 2018 Sep 1;143(5):1017-1028. doi: 10.1002/ijc.31297. Epub 2018 Mar 5.
|
| 40 |
Circ-ATP8A2 promotes cell proliferation and invasion as a ceRNA to target EGFR by sponging miR-433 in cervical cancer.Gene. 2019 Jul 15;705:103-108. doi: 10.1016/j.gene.2019.04.068. Epub 2019 Apr 25.
|
| 41 |
Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer.BMC Cancer. 2018 Mar 27;18(1):349. doi: 10.1186/s12885-018-4243-7.
|
| 42 |
FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.J Cancer Res Clin Oncol. 2019 Aug;145(8):2013-2025. doi: 10.1007/s00432-019-02951-x. Epub 2019 Jun 8.
|
| 43 |
Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia.Mol Med. 1995 Jan;1(2):161-71.
|
| 44 |
Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.PLoS One. 2015 Nov 16;10(11):e0142501. doi: 10.1371/journal.pone.0142501. eCollection 2015.
|
| 45 |
Interleukin-1 Gene Cluster Polymorphisms and its Haplotypes may Predict the Risk to Develop Cervical Cancer in Tunisia.Pathol Oncol Res. 2015 Sep;21(4):1101-7. doi: 10.1007/s12253-015-9941-8. Epub 2015 Apr 30.
|
| 46 |
Laparoscopic surgery for early cervical squamous cell carcinoma and its effect on the micrometastasis of cancer cells.Medicine (Baltimore). 2018 Aug;97(34):e11921. doi: 10.1097/MD.0000000000011921.
|
| 47 |
RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.Cancer Lett. 2020 Jan 28;469:287-300. doi: 10.1016/j.canlet.2019.11.002. Epub 2019 Nov 6.
|
| 48 |
Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.Cancer Res. 2003 Dec 1;63(23):8173-80.
|
| 49 |
Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions.J Med Virol. 1996 May;49(1):15-22. doi: 10.1002/(SICI)1096-9071(199605)49:1<15::AID-JMV3>3.0.CO;2-N.
|
| 50 |
A retinoid responsive cytokine gene, MK, is preferentially expressed in the proximal tubules of the kidney and human tumor cell lines.Am J Pathol. 1993 Feb;142(2):425-31.
|
| 51 |
Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.Biomed Pharmacother. 2019 Apr;112:108602. doi: 10.1016/j.biopha.2019.108602. Epub 2019 Feb 18.
|
| 52 |
miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51.J Cell Physiol. 2020 Jan;235(1):185-193. doi: 10.1002/jcp.28957. Epub 2019 Jun 12.
|
| 53 |
Up-regulation of the amino acid transporter ATB(0,+) (SLC6A14) in carcinoma of the cervix.Gynecol Oncol. 2006 Jan;100(1):8-13. doi: 10.1016/j.ygyno.2005.08.016. Epub 2005 Sep 15.
|
| 54 |
LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway.Biochem Biophys Res Commun. 2007 Nov 9;363(1):82-8. doi: 10.1016/j.bbrc.2007.08.127. Epub 2007 Aug 30.
|
| 55 |
Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene.Hum Genet. 2007 Aug;122(1):71-81. doi: 10.1007/s00439-007-0375-6. Epub 2007 May 22.
|
| 56 |
REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.Oncogene. 2019 Oct;38(43):6940-6957. doi: 10.1038/s41388-019-0906-3. Epub 2019 Aug 13.
|
| 57 |
TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.PLoS Pathog. 2017 Oct 18;13(10):e1006681. doi: 10.1371/journal.ppat.1006681. eCollection 2017 Oct.
|
| 58 |
Effects of A.marina-Derived Isoquercitrin on TNF-Related Apoptosis-Inducing Ligand Receptor (TRAIL-R) Expression and Apoptosis Induction in Cervical Cancer Cells.Appl Biochem Biotechnol. 2017 Jun;182(2):697-707. doi: 10.1007/s12010-016-2355-6. Epub 2016 Dec 24.
|
| 59 |
USP8 suppresses death receptor-mediated apoptosis by enhancing FLIP(L) stability.Oncogene. 2017 Jan 26;36(4):458-470. doi: 10.1038/onc.2016.215. Epub 2016 Jun 20.
|
| 60 |
Effects of shRNA-mediated silencing of PSMA7 on cell proliferation and vascular endothelial growth factor expression via the ubiquitin-proteasome pathway in cervical cancer.J Cell Physiol. 2019 May;234(5):5851-5862. doi: 10.1002/jcp.26408. Epub 2018 Dec 11.
|
| 61 |
Synchronous coexpression of Id? and nuclear NFB p65 promotes cervical cancer progression and malignancy, and is associated with a poor prognosis and chemosensitivity.Oncol Rep. 2019 Nov;42(5):2075-2086. doi: 10.3892/or.2019.7301. Epub 2019 Sep 5.
|
| 62 |
CD83 polymorphisms and cervical cancer risk.Gynecol Oncol. 2009 Aug;114(2):319-22. doi: 10.1016/j.ygyno.2009.04.033. Epub 2009 May 15.
|
| 63 |
DNA methylation profile at the DNMT3L promoter: a potential biomarker for cervical cancer.Epigenetics. 2007 Apr-Jun;2(2):80-5. doi: 10.4161/epi.2.2.3692. Epub 2006 Dec 7.
|
| 64 |
Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer.Ann Oncol. 2009 Jan;20(1):63-70. doi: 10.1093/annonc/mdn556. Epub 2008 Aug 9.
|
| 65 |
Angiogenesis in cervical cancer is mediated by HeLa metabolites through endothelial cell tissue kallikrein.Oncol Rep. 2009 Aug;22(2):285-93.
|
| 66 |
Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis.Clin Cancer Res. 2008 Mar 15;14(6):1686-91. doi: 10.1158/1078-0432.CCR-07-4085.
|
| 67 |
Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.J Infect Dis. 2008 Feb 1;197(3):371-81. doi: 10.1086/524300.
|
| 68 |
Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.Mol Cancer. 2008 Jun 17;7:58. doi: 10.1186/1476-4598-7-58.
|
| 69 |
A new cytotoxic polycyclic polyprenylated acylphloroglucinol from Garcinia nujiangensis screened by the LC-PDA and LC-MS.Nat Prod Res. 2020 Sep;34(17):2448-2455. doi: 10.1080/14786419.2018.1539983. Epub 2019 Jan 9.
|
| 70 |
The association between RAR and FHIT promoter methylation and the carcinogenesis of patients with cervical carcinoma: A meta-analysis.Tumour Biol. 2017 Jun;39(6):1010428317709126. doi: 10.1177/1010428317709126.
|
| 71 |
Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells.Cancer Sci. 2018 May;109(5):1357-1368. doi: 10.1111/cas.13563. Epub 2018 Apr 24.
|
| 72 |
SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/-catenin signaling pathway via trans-suppressing -catenin in cervical cancer.Cell Death Dis. 2018 Jul 3;9(7):741. doi: 10.1038/s41419-018-0782-8.
|
| 73 |
ADAM9 Expression in Uterine Cervical Cancer and Its Associated Factors.Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1081-1087. doi: 10.31557/APJCP.2019.20.4.1081.
|
| 74 |
Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.Int J Gynecol Cancer. 2016 Jan;26(1):176-83. doi: 10.1097/IGC.0000000000000582.
|
| 75 |
TP53 mediated miR-3647-5p prevents progression of cervical carcinoma by targeting AGR2.Cancer Med. 2019 Oct;8(13):6095-6105. doi: 10.1002/cam4.2507. Epub 2019 Aug 22.
|
| 76 |
Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix.Gynecol Oncol. 2014 Feb;132(2):474-82. doi: 10.1016/j.ygyno.2013.11.032. Epub 2013 Dec 4.
|
| 77 |
AT-406, an IAP inhibitor, activates apoptosis and induces radiosensitization of normoxic and hypoxic cervical cancer cells.J Pharmacol Sci. 2014;126(1):56-65. doi: 10.1254/jphs.14079fp. Epub 2014 Aug 27.
|
| 78 |
Expression of AMHR2 and C-KIT in cervical lesions in Uyghur Women of Xinjiang, China.Medicine (Baltimore). 2018 Jun;97(22):e10793. doi: 10.1097/MD.0000000000010793.
|
| 79 |
Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo.Cancer Chemother Pharmacol. 2015 Mar;75(3):465-74. doi: 10.1007/s00280-014-2658-7. Epub 2015 Jan 1.
|
| 80 |
Correlation of APOBEC3G Polymorphism with Human Papillomavirus (HPV) Persistent Infection and Progression of Cervical Lesions.Med Sci Monit. 2019 Sep 17;25:6990-6997. doi: 10.12659/MSM.916142.
|
| 81 |
LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis.J Cell Biochem. 2020 Jan;121(1):344-352. doi: 10.1002/jcb.29181. Epub 2019 Jun 24.
|
| 82 |
Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.Oncol Rep. 2015 May;33(5):2337-44. doi: 10.3892/or.2015.3867. Epub 2015 Mar 20.
|
| 83 |
miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2.Oncol Res. 2017 Apr 14;25(4):463-470. doi: 10.3727/096504016X14685034103879.
|
| 84 |
Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2.Int J Oncol. 2019 Jul;55(1):131-141. doi: 10.3892/ijo.2019.4792. Epub 2019 May 2.
|
| 85 |
Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/BMI-1 signaling.Life Sci. 2019 Oct 15;235:116785. doi: 10.1016/j.lfs.2019.116785. Epub 2019 Aug 21.
|
| 86 |
Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma.Front Oncol. 2018 Oct 23;8:465. doi: 10.3389/fonc.2018.00465. eCollection 2018.
|
| 87 |
Hyaluronic acid binding protein 1 overexpression is an indicator for disease-free survival in cervical cancer.Int J Clin Oncol. 2017 Apr;22(2):347-352. doi: 10.1007/s10147-016-1077-7. Epub 2016 Dec 30.
|
| 88 |
Carbonic anhydrase XII expression is associated with histologic grade of cervical cancer and superior radiotherapy outcome.Radiat Oncol. 2010 Nov 1;5:101. doi: 10.1186/1748-717X-5-101.
|
| 89 |
Using amide proton transfer to identify cervical squamous carcinoma/adenocarcinoma and evaluate its differentiation grade.Magn Reson Imaging. 2019 Sep;61:9-15. doi: 10.1016/j.mri.2019.05.005. Epub 2019 May 6.
|
| 90 |
SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.Cell Cycle. 2018;17(4):448-458. doi: 10.1080/15384101.2017.1395533. Epub 2018 Feb 8.
|
| 91 |
Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis.Radiat Oncol. 2018 Sep 14;13(1):177. doi: 10.1186/s13014-018-1126-7.
|
| 92 |
CASP7 variants modify susceptibility to cervical cancer in Chinese women.Sci Rep. 2015 Mar 18;5:9225. doi: 10.1038/srep09225.
|
| 93 |
Overexpression of carbonyl reductase 1 inhibits malignant behaviors and epithelial mesenchymal transition by suppressing TGF- signaling in uterine leiomyosarcoma cells.Oncol Lett. 2019 Aug;18(2):1503-1512. doi: 10.3892/ol.2019.10429. Epub 2019 May 31.
|
| 94 |
CBX7 Inhibits Cell Growth and Motility and Induces Apoptosis in Cervical Cancer Cells.Mol Ther Oncolytics. 2019 Sep 24;15:108-116. doi: 10.1016/j.omto.2019.09.002. eCollection 2019 Dec 20.
|
| 95 |
LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis.BMC Cancer. 2019 Nov 28;19(1):1157. doi: 10.1186/s12885-019-6326-5.
|
| 96 |
ESRP1 Induces Cervical Cancer Cell G1-Phase Arrest Via Regulating Cyclin A2 mRNA Stability.Int J Mol Sci. 2019 Jul 29;20(15):3705. doi: 10.3390/ijms20153705.
|
| 97 |
LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.Carcinogenesis. 2020 Mar 13;41(1):111-121. doi: 10.1093/carcin/bgz166.
|
| 98 |
Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer.Anticancer Res. 2003 Sep-Oct;23(5A):3929-35.
|
| 99 |
CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study.Mem Inst Oswaldo Cruz. 2016 Mar;111(3):174-80. doi: 10.1590/0074-02760150367. Epub 2016 Mar 15.
|
| 100 |
CD44+/CD24+-Expressing Cervical Cancer Cells and Radioresistant Cervical Cancer Cells Exhibit Cancer Stem Cell Characteristics.Gynecol Obstet Invest. 2019;84(2):174-182. doi: 10.1159/000493129. Epub 2018 Oct 12.
|
| 101 |
Immunoscore system combining CD8 and PD-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer.Int J Biol Markers. 2020 Mar;35(1):65-73. doi: 10.1177/1724600819888771. Epub 2019 Dec 6.
|
| 102 |
Identification of CD28 and PTEN as novel prognostic markers for cervical cancer.J Cell Physiol. 2019 May;234(5):7004-7011. doi: 10.1002/jcp.27453. Epub 2018 Oct 26.
|
| 103 |
Cooperation of decay-accelerating factor and membrane cofactor protein in regulating survival of human cervical cancer cells.BMC Cancer. 2009 Oct 30;9:384. doi: 10.1186/1471-2407-9-384.
|
| 104 |
Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.J Pathol. 2018 Feb;244(2):151-163. doi: 10.1002/path.4991. Epub 2017 Dec 19.
|
| 105 |
Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.PLoS One. 2013;8(2):e55975. doi: 10.1371/journal.pone.0055975. Epub 2013 Feb 6.
|
| 106 |
Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G?M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.Oncol Rep. 2015 May;33(5):2639-47. doi: 10.3892/or.2015.3871. Epub 2015 Mar 20.
|
| 107 |
An interaction network driven approach for identifying biomarkers for progressing cervical intraepithelial neoplasia.Sci Rep. 2018 Aug 27;8(1):12927. doi: 10.1038/s41598-018-31187-x.
|
| 108 |
Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1.Cancer Manag Res. 2019 Jun 28;11:5835-5844. doi: 10.2147/CMAR.S200907. eCollection 2019.
|
| 109 |
MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer.Biosci Rep. 2019 Jul 25;39(7):BSR20191221. doi: 10.1042/BSR20191221. Print 2019 Jul 31.
|
| 110 |
CDK7 inhibitor suppresses tumor progression through blocking the cell cycle at the G2/M phase and inhibiting transcriptional activity in cervical cancer.Onco Targets Ther. 2019 Mar 22;12:2137-2147. doi: 10.2147/OTT.S195655. eCollection 2019.
|
| 111 |
Checkpoint Kinase 1 Is Overexpressed during HPV16-Induced Cervical Carcinogenesis.Gynecol Obstet Invest. 2018;83(3):299-305. doi: 10.1159/000487943. Epub 2018 Apr 5.
|
| 112 |
CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.Arch Gynecol Obstet. 2016 Aug;294(2):333-42. doi: 10.1007/s00404-015-3985-6. Epub 2015 Dec 22.
|
| 113 |
The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells.PLoS Pathog. 2019 May 22;15(5):e1007769. doi: 10.1371/journal.ppat.1007769. eCollection 2019 May.
|
| 114 |
Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene does not affect scytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-infected women with or without cervical cancer.Indian J Med Microbiol. 2018 Apr-Jun;36(2):207-210. doi: 10.4103/ijmm.IJMM_17_220.
|
| 115 |
Effects of DCK knockdown on proliferation, apoptosis and tumorigenicity in vivo of cervical cancer HeLa cells.Cancer Gene Ther. 2017 Sep;24(9):367-372. doi: 10.1038/cgt.2017.31. Epub 2017 Aug 18.
|
| 116 |
p68 prompts the epithelial-mesenchymal transition in cervical cancer cells by transcriptionally activating the TGF-1 signaling pathway.Oncol Lett. 2018 Feb;15(2):2111-2116. doi: 10.3892/ol.2017.7552. Epub 2017 Dec 8.
|
| 117 |
Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3/p-Tyr216-GSK-3/-catenin axis.Oncol Rep. 2017 Aug;38(2):1035-1042. doi: 10.3892/or.2017.5721. Epub 2017 Jun 14.
|
| 118 |
Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.Tumori. 2020 Apr;106(2):155-164. doi: 10.1177/0300891619886656. Epub 2019 Nov 18.
|
| 119 |
Negative correlation between X-linked inhibitors of apoptosis and second mitochondria-derived activator of caspase expression levels in cervical carcinoma and cervical intraepithelial neoplasia.Oncol Lett. 2017 Nov;14(5):5340-5346. doi: 10.3892/ol.2017.6878. Epub 2017 Sep 4.
|
| 120 |
MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3.Exp Ther Med. 2017 Aug;14(2):1227-1234. doi: 10.3892/etm.2017.4586. Epub 2017 Jun 13.
|
| 121 |
DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.Tumour Biol. 2016 Apr;37(4):5063-74. doi: 10.1007/s13277-015-4312-3. Epub 2015 Nov 6.
|
| 122 |
Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.Tumour Biol. 2017 May;39(5):1010428317699799. doi: 10.1177/1010428317699799.
|
| 123 |
Targeting dipeptidyl peptidase 8 genes inhibits proliferation, migration and invasion by inhibition of cyclin D1 and MMP2MMP9 signal pathway in cervical cancer.J Gene Med. 2018 Dec;20(12):e3056. doi: 10.1002/jgm.3056. Epub 2018 Nov 8.
|
| 124 |
The Deubiquitinase USP46 Is Essential for Proliferation and Tumor Growth of HPV-Transformed Cancers.Mol Cell. 2018 Dec 6;72(5):823-835.e5. doi: 10.1016/j.molcel.2018.09.019. Epub 2018 Nov 8.
|
| 125 |
Identification of Vaccinia-H1 Related Phosphatase as an Anticancer Target for 1,2,3,4,6-O-Pentagalloylglucose.Chem Biodivers. 2020 Feb;17(2):e1900414. doi: 10.1002/cbdv.201900414. Epub 2020 Jan 7.
|
| 126 |
Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1.mBio. 2019 Jan 29;10(1):e02687-18. doi: 10.1128/mBio.02687-18.
|
| 127 |
MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.Int J Gynecol Cancer. 2015 May;25(4):707-13. doi: 10.1097/IGC.0000000000000399.
|
| 128 |
Inhibiting MNK Selectively Targets Cervical Cancer via Suppressing eIF4E-Mediated -Catenin Activation.Am J Med Sci. 2019 Sep;358(3):227-234. doi: 10.1016/j.amjms.2019.05.013. Epub 2019 Jun 5.
|
| 129 |
Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.Histopathology. 2016 Aug;69(2):276-87. doi: 10.1111/his.12933. Epub 2016 Mar 17.
|
| 130 |
hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2).Mol Cell Biochem. 2011 Nov;357(1-2):55-63. doi: 10.1007/s11010-011-0875-5. Epub 2011 May 28.
|
| 131 |
Near-Infrared Light-Controlled Gene Expression and Protein Targeting in Neurons and Non-neuronal Cells.Chembiochem. 2018 Jun 18;19(12):1334-1340. doi: 10.1002/cbic.201700642. Epub 2018 Apr 14.
|
| 132 |
Systematic assessment of cervical cancer initiation and progression uncovers genetic panels for deep learning-based early diagnosis and proposes novel diagnostic and prognostic biomarkers.Oncotarget. 2017 Nov 25;8(65):109436-109456. doi: 10.18632/oncotarget.22689. eCollection 2017 Dec 12.
|
| 133 |
ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.Oncoimmunology. 2017 Jun 20;6(7):e1336594. doi: 10.1080/2162402X.2017.1336594. eCollection 2017.
|
| 134 |
Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim? and galectin?, in cervical cancer.Oncol Rep. 2019 Dec;42(6):2655-2669. doi: 10.3892/or.2019.7388. Epub 2019 Oct 24.
|
| 135 |
Inhibition of protease-activated receptor-2 induces apoptosis in cervical cancer by inhibiting signal transducer and activator of transcription-3 signaling.J Int Med Res. 2019 Mar;47(3):1330-1338. doi: 10.1177/0300060518820440. Epub 2019 Jan 30.
|
| 136 |
FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer.Tumour Biol. 2016 Nov;37(11):14873-14883. doi: 10.1007/s13277-016-5350-1. Epub 2016 Sep 19.
|
| 137 |
Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.Cancer Res. 2004 May 1;64(9):2994-7. doi: 10.1158/0008-5472.can-04-0245.
|
| 138 |
Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.BMC Cancer. 2019 Jan 7;19(1):24. doi: 10.1186/s12885-018-5149-0.
|
| 139 |
Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.Reprod Sci. 2018 Jan;25(1):86-93. doi: 10.1177/1933719117702250. Epub 2017 Apr 5.
|
| 140 |
Folate receptor alpha is associated with cervical carcinogenesis and regulates cervical cancer cells growth by activating ERK1/2/c-Fos/c-Jun.Biochem Biophys Res Commun. 2017 Sep 30;491(4):1083-1091. doi: 10.1016/j.bbrc.2017.08.015. Epub 2017 Aug 3.
|
| 141 |
Fra-1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro.Int J Oncol. 2015 Apr;46(4):1677-84. doi: 10.3892/ijo.2015.2873. Epub 2015 Feb 4.
|
| 142 |
Forkhead box protein C1 promotes cell proliferation and invasion in human cervical cancer.Mol Med Rep. 2018 Mar;17(3):4392-4398. doi: 10.3892/mmr.2018.8423. Epub 2018 Jan 11.
|
| 143 |
Role and importance of the expression of transcription factor FOXC2 in cervical cancer.Oncol Lett. 2017 Dec;14(6):6627-6631. doi: 10.3892/ol.2017.7004. Epub 2017 Sep 20.
|
| 144 |
A novel FoxM1-PSMB4 axis contributes to proliferation and progression of cervical cancer.Biochem Biophys Res Commun. 2020 Jan 15;521(3):746-752. doi: 10.1016/j.bbrc.2019.10.183. Epub 2019 Nov 5.
|
| 145 |
Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.Oncol Rep. 2016 May;35(5):3106-14. doi: 10.3892/or.2016.4651. Epub 2016 Mar 3.
|
| 146 |
MTBHsp70-exFPR1-pulsed Dendritic Cells Enhance the Immune Response against Cervical Cancer.J Cancer. 2019 Oct 19;10(25):6364-6373. doi: 10.7150/jca.29779. eCollection 2019.
|
| 147 |
Effect of Follicle Stimulating Hormone Receptor Gene Polymorphisms in Cervical Cancer Risk.Pathol Oncol Res. 2017 Jul;23(3):565-572. doi: 10.1007/s12253-016-0152-8. Epub 2016 Nov 14.
|
| 148 |
Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7307-7313. doi: 10.26355/eurrev_201909_18836.
|
| 149 |
Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.Med Oncol. 2015 Apr;32(4):102. doi: 10.1007/s12032-015-0552-8. Epub 2015 Mar 5.
|
| 150 |
The impact of GGH -401C>T polymorphism on cisplatin-based chemoradiotherapy response and survival in cervical cancer.Gene. 2013 Jan 10;512(2):247-50. doi: 10.1016/j.gene.2012.10.038. Epub 2012 Oct 26.
|
| 151 |
Cx32 inhibits TNF-induced extrinsic apoptosis with and without EGFR suppression.Oncol Rep. 2017 Nov;38(5):2885-2892. doi: 10.3892/or.2017.5950. Epub 2017 Sep 7.
|
| 152 |
CCAT-1 promotes proliferation and inhibits apoptosis of cervical cancer cells via the Wnt signaling pathway.Oncotarget. 2017 Jul 10;8(40):68059-68070. doi: 10.18632/oncotarget.19155. eCollection 2017 Sep 15.
|
| 153 |
Interaction between 17-estradiol, prolactin and human papillomavirus induce E6/E7 transcript and modulate the expression and localization of hormonal receptors.Cancer Cell Int. 2019 Sep 2;19:227. doi: 10.1186/s12935-019-0935-6. eCollection 2019.
|
| 154 |
Glycoprotein nonmetastatic melanoma protein B accelerates tumorigenesis of cervical cancer in vitro by regulating the Wnt/-catenin pathway.Braz J Med Biol Res. 2018 Nov 23;52(1):e7567. doi: 10.1590/1414-431X20187567.
|
| 155 |
Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial-mesenchymal transition by suppressing the TGF-/smad pathway via binding to GREM1.Cancer Cell Int. 2019 May 23;19:147. doi: 10.1186/s12935-019-0852-8. eCollection 2019.
|
| 156 |
Expression of transcription factor grainyhead-like 2 is diminished in cervical cancer.Int J Clin Exp Pathol. 2014 Oct 15;7(11):7409-18. eCollection 2014.
|
| 157 |
Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.Int J Oncol. 2017 Jun;50(6):1947-1954. doi: 10.3892/ijo.2017.3980. Epub 2017 May 3.
|
| 158 |
Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.Cell Commun Signal. 2018 May 2;16(1):20. doi: 10.1186/s12964-018-0231-4.
|
| 159 |
The Roles of HK2 on Tumorigenesis of Cervical Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819871306. doi: 10.1177/1533033819871306.
|
| 160 |
A cis-eQTL of HLA-DRB1 and a frameshift mutation of MICA contribute to the pattern of association of HLA alleles with cervical cancer.Cancer Med. 2014 Apr;3(2):445-52. doi: 10.1002/cam4.192. Epub 2014 Feb 12.
|
| 161 |
Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women.Eur J Cancer. 2014 Jan;50(2):469-74. doi: 10.1016/j.ejca.2013.10.018. Epub 2013 Nov 18.
|
| 162 |
The proliferation of cervical cancer is promoted by miRNA-125b through the regulation of the HMGA1.Onco Targets Ther. 2019 Apr 11;12:2767-2776. doi: 10.2147/OTT.S197740. eCollection 2019.
|
| 163 |
High-mobility group box 2 promoted proliferation of cervical cancer cells by activating AKT signaling pathway.J Cell Biochem. 2019 Oct;120(10):17345-17353. doi: 10.1002/jcb.28998. Epub 2019 Jun 18.
|
| 164 |
HNRNPA1, a Splicing Regulator, Is an Effective Target Protein for Cervical Cancer Detection: Comparison With Conventional Tumor Markers.Int J Gynecol Cancer. 2017 Feb;27(2):326-331. doi: 10.1097/IGC.0000000000000868.
|
| 165 |
Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.Oncol Rep. 2018 Mar;39(3):939-950. doi: 10.3892/or.2018.6195. Epub 2018 Jan 5.
|
| 166 |
The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.Oncotarget. 2016 Dec 13;7(50):83001-83016. doi: 10.18632/oncotarget.12863.
|
| 167 |
Long Non-coding RNA DLEU1 Promotes Proliferation and Invasion by Interacting With miR-381 and Enhancing HOXA13 Expression in Cervical Cancer.Front Genet. 2018 Dec 7;9:629. doi: 10.3389/fgene.2018.00629. eCollection 2018.
|
| 168 |
HOXA5 inhibits the proliferation and induces the apoptosis of cervical cancer cells via regulation of protein kinase B and p27.Oncol Rep. 2019 Feb;41(2):1122-1130. doi: 10.3892/or.2018.6874. Epub 2018 Nov 20.
|
| 169 |
Increased expression of HOXB2 and HOXB13 proteins is associated with HPV infection and cervical cancer progression.Asian Pac J Cancer Prev. 2015;16(4):1349-53. doi: 10.7314/apjcp.2015.16.4.1349.
|
| 170 |
Interleukin?7A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer.Int J Oncol. 2018 Oct;53(4):1809-1817. doi: 10.3892/ijo.2018.4503. Epub 2018 Jul 26.
|
| 171 |
Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells.Tumour Biol. 2014 Jan;35(1):403-10. doi: 10.1007/s13277-013-1056-9. Epub 2013 Aug 9.
|
| 172 |
Blocking IDO1 Helps Shrink Bladder, Cervical Tumors.Cancer Discov. 2018 Jan;8(1):OF3. doi: 10.1158/2159-8290.CD-NB2017-167. Epub 2017 Nov 22.
|
| 173 |
Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients.Clin Biochem. 2016 Aug;49(12):919-24. doi: 10.1016/j.clinbiochem.2016.04.008. Epub 2016 Apr 20.
|
| 174 |
Persistence rate of cervical human papillomavirus infections and abnormal cytology in Rwanda.HIV Med. 2019 Aug;20(7):485-495. doi: 10.1111/hiv.12782.
|
| 175 |
Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer.Pathol Oncol Res. 2012 Oct;18(4):997-1002. doi: 10.1007/s12253-012-9532-x. Epub 2012 May 22.
|
| 176 |
A novel microRNA, hsa-miR-6852 differentially regulated by Interleukin-27 induces necrosis in cervical cancer cells by downregulating the FoxM1 expression.Sci Rep. 2018 Jan 17;8(1):900. doi: 10.1038/s41598-018-19259-4.
|
| 177 |
Relationship of IL-17A and IL-17F genetic variations to cervical cancer risk: a meta-analysis.Biomark Med. 2017 May;11(5):459-471. doi: 10.2217/bmm-2016-0315.
|
| 178 |
The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case-control study.Mol Genet Genomic Med. 2019 Jan;7(1):e00516. doi: 10.1002/mgg3.516. Epub 2018 Nov 20.
|
| 179 |
SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-B-CD47 axis.Oncogene. 2018 May;37(18):2394-2409. doi: 10.1038/s41388-017-0119-6. Epub 2018 Feb 12.
|
| 180 |
Combination of IL-24 and cisplatin inhibits cervical cancer growth in a xenograft nude mice model.Asian Pac J Cancer Prev. 2011;12(12):3293-8.
|
| 181 |
Inhibition of human cervical cancer cell invasion by IL-37 involving runt related transcription factor 2 suppression.Ann Transl Med. 2019 Oct;7(20):568. doi: 10.21037/atm.2019.09.38.
|
| 182 |
BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer.PLoS One. 2015 Feb 6;10(2):e0117035. doi: 10.1371/journal.pone.0117035. eCollection 2015.
|
| 183 |
Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.BMC Cancer. 2018 Dec 3;18(1):1197. doi: 10.1186/s12885-018-5125-8.
|
| 184 |
Long non-coding RNA activated by transforming growth factor- promotes proliferation and invasion of cervical cancer cells by regulating the miR-144/ITGA6 axis.Exp Physiol. 2019 Jun;104(6):837-844. doi: 10.1113/EP087656. Epub 2019 Apr 8.
|
| 185 |
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in ce... Oncoimmunology. 2017 Jul 24;6(9):e1338230.
|
| 186 |
ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women.Oncotarget. 2017 Feb 7;8(6):10085-10090. doi: 10.18632/oncotarget.14341.
|
| 187 |
Silencing of KCNA1 suppresses the cervical cancer development via mitochondria damage.Channels (Austin). 2019 Dec;13(1):321-330. doi: 10.1080/19336950.2019.1648627.
|
| 188 |
Eag1 potassium channels as markers of cervical dysplasia.Oncol Rep. 2011 Dec;26(6):1377-83. doi: 10.3892/or.2011.1441. Epub 2011 Aug 31.
|
| 189 |
Men's awareness of cervical cancer: a qualitative study.BMC Womens Health. 2018 Sep 24;18(1):155. doi: 10.1186/s12905-018-0650-9.
|
| 190 |
HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway.J Cell Physiol. 2019 Mar;234(3):2659-2671. doi: 10.1002/jcp.27080. Epub 2018 Aug 21.
|
| 191 |
KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.Int J Biol Macromol. 2019 Apr 1;126:318-325. doi: 10.1016/j.ijbiomac.2018.12.105. Epub 2018 Dec 20.
|
| 192 |
JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR?91?p.Mol Med Rep. 2019 Apr;19(4):2489-2496. doi: 10.3892/mmr.2019.9916. Epub 2019 Jan 31.
|
| 193 |
High expression of Kruppel-like factor 4 as a predictor of poor prognosis for cervical cancer patient response to radiotherapy.Tumour Biol. 2017 Jun;39(6):1010428317710225. doi: 10.1177/1010428317710225.
|
| 194 |
The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.Am J Obstet Gynecol. 2004 Jan;190(1):60-6. doi: 10.1016/j.ajog.2003.07.020.
|
| 195 |
Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.BMC Immunol. 2012 Feb 8;13:7. doi: 10.1186/1471-2172-13-7.
|
| 196 |
Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.Oncol Rep. 2017 Jul;38(1):159-166. doi: 10.3892/or.2017.5663. Epub 2017 May 23.
|
| 197 |
Bradykinin promotes proliferation, migration, and invasion of cervical cancer cells through STAT3 signaling pathways.Oncol Rep. 2019 Dec;42(6):2521-2527. doi: 10.3892/or.2019.7380. Epub 2019 Oct 18.
|
| 198 |
KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.Oncotarget. 2017 May 16;8(20):32833-32847. doi: 10.18632/oncotarget.15834.
|
| 199 |
KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.Life Sci. 2019 May 1;224:255-262. doi: 10.1016/j.lfs.2019.03.065. Epub 2019 Mar 27.
|
| 200 |
Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.Tumour Biol. 2016 Apr;37(4):4849-55. doi: 10.1007/s13277-015-4319-9. Epub 2015 Nov 2.
|
| 201 |
Knockdown of Legumain Suppresses Cervical Cancer Cell Migration and Invasion.Oncol Res. 2016 Jan 21;23(1-2):7-12. doi: 10.3727/096504015X14410238486649.
|
| 202 |
LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.Cell Death Dis. 2017 Sep 7;8(9):e3039. doi: 10.1038/cddis.2017.393.
|
| 203 |
MicroRNA-10a-5p suppresses cancer proliferation and division in human cervical cancer by targeting BDNF.Exp Ther Med. 2017 Dec;14(6):6147-6151. doi: 10.3892/etm.2017.5312. Epub 2017 Oct 16.
|
| 204 |
CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.Int J Mol Sci. 2019 May 7;20(9):2262. doi: 10.3390/ijms20092262.
|
| 205 |
Association between Toll-like receptor and tumor necrosis factor immunological pathways in uterine cervical neoplasms.Tumori. 2017 Jan 21;103(1):81-86. doi: 10.5301/tj.5000576. Epub 2016 Nov 15.
|
| 206 |
Tyrosine kinase LYN is an oncotarget in human cervical cancer: A quantitative proteomic based study.Oncotarget. 2016 Nov 15;7(46):75468-75481. doi: 10.18632/oncotarget.12258.
|
| 207 |
MLK3 silence induces cervical cancer cell apoptosis via the Notch-1/autophagy network.Clin Exp Pharmacol Physiol. 2019 Sep;46(9):854-860. doi: 10.1111/1440-1681.13123. Epub 2019 Jul 3.
|
| 208 |
MEKK3 and survivin expression in cervical cancer: association with clinicopathological factors and prognosis.Asian Pac J Cancer Prev. 2014;15(13):5271-6. doi: 10.7314/apjcp.2014.15.13.5271.
|
| 209 |
MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4.Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):623-631. doi: 10.26355/eurrev_201802_14286.
|
| 210 |
Cervical Cancer Cells-Secreted Exosomal microRNA-221-3p Promotes Invasion, Migration and Angiogenesis of Microvascular Endothelial Cells in Cervical Cancer by Down-Regulating MAPK10 Expression.Cancer Manag Res. 2019 Dec 9;11:10307-10319. doi: 10.2147/CMAR.S221527. eCollection 2019.
|
| 211 |
MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression.Front Immunol. 2018 Nov 23;9:2742. doi: 10.3389/fimmu.2018.02742. eCollection 2018.
|
| 212 |
Association of MBL2 exon1 polymorphisms with high-risk human papillomavirus infection and cervical cancers: a meta-analysis.Arch Gynecol Obstet. 2016 Nov;294(6):1109-1116. doi: 10.1007/s00404-016-4201-z. Epub 2016 Sep 13.
|
| 213 |
Evaluation of tissue-specific promoters in carcinomas of the cervix uteri.J Gene Med. 2004 Nov;6(11):1281-9. doi: 10.1002/jgm.606.
|
| 214 |
Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer.J Immunother. 2018 May;41(4):201-207. doi: 10.1097/CJI.0000000000000214.
|
| 215 |
Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4680-4687. doi: 10.26355/eurrev_201906_18049.
|
| 216 |
MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma.Front Oncol. 2019 Jan 29;9:29. doi: 10.3389/fonc.2019.00029. eCollection 2019.
|
| 217 |
Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.Int J Med Sci. 2019 Jun 2;16(6):774-782. doi: 10.7150/ijms.33195. eCollection 2019.
|
| 218 |
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.J Obstet Gynaecol Res. 2018 Jul;44(7):1274-1283. doi: 10.1111/jog.13659. Epub 2018 May 16.
|
| 219 |
Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.Clin Epigenetics. 2019 Aug 19;11(1):120. doi: 10.1186/s13148-019-0719-9.
|
| 220 |
Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.Hum Pathol. 2017 Jul;65:53-61. doi: 10.1016/j.humpath.2016.12.026. Epub 2017 Jan 11.
|
| 221 |
Musashi-2 is a prognostic marker for the survival of patients with cervical cancer.Oncol Lett. 2018 Apr;15(4):5425-5432. doi: 10.3892/ol.2018.8077. Epub 2018 Feb 16.
|
| 222 |
Mesothelin as a target for cervical cancer therapy.Arch Gynecol Obstet. 2019 Jan;299(1):211-216. doi: 10.1007/s00404-018-4933-z. Epub 2018 Oct 15.
|
| 223 |
Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-B/APOBEC3B cascade.Cancer Chemother Pharmacol. 2019 Apr;83(4):625-637. doi: 10.1007/s00280-018-03766-2. Epub 2019 Jan 10.
|
| 224 |
Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis.Pathol Oncol Res. 2020 Apr;26(2):791-800. doi: 10.1007/s12253-019-00626-z. Epub 2019 Feb 28.
|
| 225 |
Altered expression of lncRNA NCK1-AS1 distinguished patients with prostate cancer from those with benign prostatic hyperplasia.Oncol Lett. 2019 Dec;18(6):6379-6384. doi: 10.3892/ol.2019.11039. Epub 2019 Nov 1.
|
| 226 |
Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.PLoS One. 2016 Apr 26;11(4):e0153274. doi: 10.1371/journal.pone.0153274. eCollection 2016.
|
| 227 |
GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1 not STAT3 in Hela cells.Tumour Biol. 2016 Jul;37(7):9789-96. doi: 10.1007/s13277-016-4877-5. Epub 2016 Jan 25.
|
| 228 |
The role of the hypoxia-Nrp-1 axis in the activation of M2-like tumor-associated macrophages in the tumor microenvironment of cervical cancer.Mol Carcinog. 2019 Mar;58(3):388-397. doi: 10.1002/mc.22936. Epub 2018 Nov 18.
|
| 229 |
Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.J Clin Pathol. 2006 Oct;59(10):1044-51. doi: 10.1136/jcp.2005.033142. Epub 2006 Mar 14.
|
| 230 |
Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer.Exp Cell Res. 2019 Mar 1;376(1):27-38. doi: 10.1016/j.yexcr.2019.01.014. Epub 2019 Jan 26.
|
| 231 |
Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes Cancer. 2014 May;5(5-6):154-64. doi: 10.18632/genesandcancer.15.
|
| 232 |
ARFHPV E7 oncogene, lncRNA HOTAIR, miR-331-3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer.J Cell Biochem. 2018 Jun;119(6):4397-4407. doi: 10.1002/jcb.26503. Epub 2018 Mar 7.
|
| 233 |
Cervical cancer cells produce TGF-1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-1.Cytokine. 2019 Jun;118:71-79. doi: 10.1016/j.cyto.2018.09.018. Epub 2018 Oct 6.
|
| 234 |
PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.Diagn Pathol. 2015 Sep 28;10:177. doi: 10.1186/s13000-015-0404-z.
|
| 235 |
microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.J Cell Biochem. 2018 Jul;119(7):5243-5252. doi: 10.1002/jcb.26585. Epub 2018 Mar 25.
|
| 236 |
Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2.Cancer Biol Ther. 2014 Mar 1;15(3):279-88. doi: 10.4161/cbt.27223. Epub 2013 Dec 11.
|
| 237 |
Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.Clin Transl Oncol. 2019 Apr;21(4):404-411. doi: 10.1007/s12094-018-1937-x. Epub 2018 Sep 4.
|
| 238 |
Sex steroid hormone receptor expression in the vaginal wall in cervical cancer survivors after radiotherapy.Acta Oncol. 2019 Aug;58(8):1107-1115. doi: 10.1080/0284186X.2019.1598574. Epub 2019 Apr 8.
|
| 239 |
Role of PGRMC1 in cell physiology of cervical cancer.Life Sci. 2019 Aug 15;231:116541. doi: 10.1016/j.lfs.2019.06.016. Epub 2019 Jun 16.
|
| 240 |
MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.J Cell Physiol. 2019 Jun;234(6):9577-9591. doi: 10.1002/jcp.27645. Epub 2018 Nov 27.
|
| 241 |
Synthesis and Evaluation of Dibenzothiophene Analogues as Pin1 Inhibitors for Cervical Cancer Therapy.ACS Omega. 2019 May 24;4(5):9228-9234. doi: 10.1021/acsomega.9b00281. eCollection 2019 May 31.
|
| 242 |
NF-B potentiates tumor growth by suppressing a novel target LPTS.Cell Commun Signal. 2017 Oct 10;15(1):39. doi: 10.1186/s12964-017-0196-8.
|
| 243 |
Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells.Cancer Cell Int. 2019 May 14;19:129. doi: 10.1186/s12935-019-0845-7. eCollection 2019.
|
| 244 |
Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.Int J Gynecol Cancer. 2017 May;27(4):784-790. doi: 10.1097/IGC.0000000000000957.
|
| 245 |
MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.Oncotarget. 2016 Apr 12;7(15):19666-79. doi: 10.18632/oncotarget.7531.
|
| 246 |
Hypoxia and TGF-1 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formation.Cancer Cell Int. 2017 May 12;17:54. doi: 10.1186/s12935-017-0420-z. eCollection 2017.
|
| 247 |
Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability.Mol Carcinog. 2015 Nov;54(11):1301-14. doi: 10.1002/mc.22205. Epub 2014 Aug 23.
|
| 248 |
Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.Biomed Pharmacother. 2019 Dec;120:109546. doi: 10.1016/j.biopha.2019.109546. Epub 2019 Oct 30.
|
| 249 |
Effects of 60kDa prolactin and estradiol on metabolism and cell survival in cervical cancer: Coexpression of their hormonal receptors during cancer progression.Oncol Rep. 2018 Dec;40(6):3781-3793. doi: 10.3892/or.2018.6743. Epub 2018 Sep 28.
|
| 250 |
PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population.Sci Rep. 2016 Mar 22;6:23465. doi: 10.1038/srep23465.
|
| 251 |
KF-finder: identification of key factors from host-microbial networks in cervical cancer.BMC Syst Biol. 2018 Apr 24;12(Suppl 4):54. doi: 10.1186/s12918-018-0566-x.
|
| 252 |
The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.Int J Mol Sci. 2017 Jul 19;18(7):1571. doi: 10.3390/ijms18071571.
|
| 253 |
The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.Chin J Cancer. 2016 Jun 16;35(1):54. doi: 10.1186/s40880-016-0114-2.
|
| 254 |
The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer.Dis Markers. 2019 Mar 3;2019:5380197. doi: 10.1155/2019/5380197. eCollection 2019.
|
| 255 |
Divergent viral presentation among human tumors and adjacent normal tissues.Sci Rep. 2016 Jun 24;6:28294. doi: 10.1038/srep28294.
|
| 256 |
High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.mBio. 2016 Sep 20;7(5):e01530-16. doi: 10.1128/mBio.01530-16.
|
| 257 |
Early diagnosis behavior in Turkish women with and without a family history of cervical cancer.Asian Pac J Cancer Prev. 2015;16(2):401-6. doi: 10.7314/apjcp.2015.16.2.401.
|
| 258 |
CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle.PLoS One. 2017 Aug 2;12(8):e0182373. doi: 10.1371/journal.pone.0182373. eCollection 2017.
|
| 259 |
Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.Oncol Rep. 2020 Jan;43(1):41-54. doi: 10.3892/or.2019.7389. Epub 2019 Oct 25.
|
| 260 |
RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-1.Biochem Biophys Res Commun. 2018 Sep 3;503(1):86-93. doi: 10.1016/j.bbrc.2018.05.183. Epub 2018 Jun 11.
|
| 261 |
Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis.Oncol Lett. 2018 Oct;16(4):5200-5208. doi: 10.3892/ol.2018.9323. Epub 2018 Aug 17.
|
| 262 |
High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer.Oncol Res. 2017 Apr 14;25(4):495-501. doi: 10.3727/096504016X14749735594687. Epub 2016 Sep 30.
|
| 263 |
A H2AX?CARP-1 Interaction Regulates Apoptosis Signaling Following DNA Damage. Cancers (Basel). 2019 Feb 14;11(2):221. doi: 10.3390/cancers11020221.
|
| 264 |
LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p.J Cell Physiol. 2019 May;234(5):7266-7278. doi: 10.1002/jcp.27484. Epub 2018 Oct 26.
|
| 265 |
RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.J Exp Clin Cancer Res. 2019 Sep 5;38(1):392. doi: 10.1186/s13046-019-1385-7.
|
| 266 |
Np63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.PLoS One. 2019 Apr 11;14(4):e0214867. doi: 10.1371/journal.pone.0214867. eCollection 2019.
|
| 267 |
Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. Br J Cancer. 2002 Jan 21;86(2):274-81.
|
| 268 |
Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.J Cell Physiol. 2019 Dec;234(12):23349-23359. doi: 10.1002/jcp.28902. Epub 2019 Jun 6.
|
| 269 |
Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.BMC Cancer. 2006 Apr 9;6:88. doi: 10.1186/1471-2407-6-88.
|
| 270 |
Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.Microvasc Res. 2014 May;93:1-8. doi: 10.1016/j.mvr.2014.02.007. Epub 2014 Mar 3.
|
| 271 |
Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis.Oncol Lett. 2019 Jun;17(6):5453-5468. doi: 10.3892/ol.2019.10227. Epub 2019 Apr 8.
|
| 272 |
HPV test by Hybrid Capture II for the diagnosis of HR-HPV persistent infection.Med Mal Infect. 2017 Nov;47(7):484-489. doi: 10.1016/j.medmal.2017.05.013. Epub 2017 Sep 22.
|
| 273 |
Correction: Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation.Oncotarget. 2017 Aug 14;8(33):55767. doi: 10.18632/oncotarget.20269. eCollection 2017 Aug 15.
|
| 274 |
Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.Radiother Oncol. 2017 May;123(2):312-318. doi: 10.1016/j.radonc.2017.03.005. Epub 2017 Mar 25.
|
| 275 |
SPAK mediates KCC3-enhanced cervical cancer tumorigenesis.FEBS J. 2014 May;281(10):2353-65. doi: 10.1111/febs.12787. Epub 2014 Apr 7.
|
| 276 |
Hospitalization outcomes and racial disparities in cervical cancer patients: An analysis of the national inpatient sample data from 2002 to 2014.Cancer Epidemiol. 2019 Dec;63:101620. doi: 10.1016/j.canep.2019.101620. Epub 2019 Oct 18.
|
| 277 |
Elevation of miR-27b by HPV16 E7 inhibits PPAR expression and promotes proliferation and invasion in cervical carcinoma cells.Int J Oncol. 2015 Nov;47(5):1759-66. doi: 10.3892/ijo.2015.3162. Epub 2015 Sep 14.
|
| 278 |
SMYD2 promotes cervical cancer growth by stimulating cell proliferation.Cell Biosci. 2019 Sep 18;9:75. doi: 10.1186/s13578-019-0340-9. eCollection 2019.
|
| 279 |
Silencing of Synuclein- inhibits human cervical cancer through the AKT signaling pathway.Cell Mol Biol Lett. 2019 Jul 10;24:49. doi: 10.1186/s11658-019-0172-y. eCollection 2019.
|
| 280 |
Protein Expression Analysis in Uterine Cervical Cancer for Potential Targets in Treatment.Pathol Oncol Res. 2019 Apr;25(2):493-501. doi: 10.1007/s12253-018-0401-0. Epub 2018 Mar 12.
|
| 281 |
Single nucleotide polymorphisms in microRNA genes are associated with cervical cancer susceptibility in a population from Xinjiang Uygur.Oncotarget. 2016 Nov 1;7(44):71447-71454. doi: 10.18632/oncotarget.12212.
|
| 282 |
Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro.Tumour Biol. 2015 Sep;36(10):7725-33. doi: 10.1007/s13277-015-3450-y. Epub 2015 May 3.
|
| 283 |
STC1 promotes cell apoptosis via NF-B phospho-P65 Ser536 in cervical cancer cells.Oncotarget. 2017 Jul 11;8(28):46249-46261. doi: 10.18632/oncotarget.17641.
|
| 284 |
Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients.PLoS One. 2016 May 31;11(5):e0156259. doi: 10.1371/journal.pone.0156259. eCollection 2016.
|
| 285 |
Prognostic and predictive roles of microRNA?11 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer.Mol Med Rep. 2020 Jan;21(1):267-281. doi: 10.3892/mmr.2019.10826. Epub 2019 Nov 20.
|
| 286 |
A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells.Exp Cell Res. 2019 May 15;378(2):206-216. doi: 10.1016/j.yexcr.2019.02.010. Epub 2019 Feb 14.
|
| 287 |
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions.Oncogenesis. 2018 Jan 23;7(1):4. doi: 10.1038/s41389-017-0018-2.
|
| 288 |
TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling.Gynecol Oncol. 2019 Jan;152(1):185-193. doi: 10.1016/j.ygyno.2018.10.039. Epub 2018 Nov 12.
|
| 289 |
Transgelin 2 overexpression inhibits cervical cancer cell invasion and migration.Mol Med Rep. 2019 Jun;19(6):4919-4926. doi: 10.3892/mmr.2019.10116. Epub 2019 Apr 3.
|
| 290 |
No association of TAP1 and TAP2 genes polymorphism with risk of cervical cancer in north Indian population.J Assist Reprod Genet. 2009 Apr;26(4):173-8. doi: 10.1007/s10815-009-9301-2. Epub 2009 Mar 5.
|
| 291 |
Role of Long Noncoding RNA 799 in the Metastasis of Cervical Cancer through Upregulation of TBL1XR1 Expression.Mol Ther Nucleic Acids. 2018 Dec 7;13:580-589. doi: 10.1016/j.omtn.2018.10.007. Epub 2018 Oct 17.
|
| 292 |
DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer.J Cell Biochem. 2019 Jun;120(6):10228-10238. doi: 10.1002/jcb.28307. Epub 2018 Dec 23.
|
| 293 |
Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.Oncotarget. 2015 Nov 17;6(36):38681-94. doi: 10.18632/oncotarget.4526.
|
| 294 |
Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.Cancer Cytopathol. 2019 Sep;127(9):586-597. doi: 10.1002/cncy.22172. Epub 2019 Aug 14.
|
| 295 |
Expression of TRF2 and its prognostic relevance in advanced stage cervical cancer patients.Biol Res. 2014 Nov 25;47(1):61. doi: 10.1186/0717-6287-47-61.
|
| 296 |
Upregulation of Tiam1 contributes to cervical cancer disease progression and indicates poor survival outcome.Hum Pathol. 2018 May;75:179-188. doi: 10.1016/j.humpath.2018.02.006. Epub 2018 Feb 13.
|
| 297 |
Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.PLoS One. 2017 May 15;12(5):e0177775. doi: 10.1371/journal.pone.0177775. eCollection 2017.
|
| 298 |
The expression of Toll-like receptor 8 and its relationship with VEGF and Bcl-2 in cervical cancer.Int J Med Sci. 2014 Apr 16;11(6):608-13. doi: 10.7150/ijms.8428. eCollection 2014.
|
| 299 |
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.Int J Mol Sci. 2019 May 2;20(9):2183. doi: 10.3390/ijms20092183.
|
| 300 |
Chemotherapeutic Drugs Inhibiting Topoisomerase 1 Activity Impede Cytokine-Induced and NF-B p65-Regulated Gene Expression.Cancers (Basel). 2019 Jun 25;11(6):883. doi: 10.3390/cancers11060883.
|
| 301 |
Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer.Cancer Res Treat. 2016 Apr;48(2):708-14. doi: 10.4143/crt.2015.098. Epub 2015 Jun 22.
|
| 302 |
CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075.J Cell Physiol. 2019 Aug;234(8):14296-14305. doi: 10.1002/jcp.28128. Epub 2019 Jan 11.
|
| 303 |
miR?46a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NFB signaling by targeting TRAF6.Oncol Rep. 2019 May;41(5):2897-2908. doi: 10.3892/or.2019.7046. Epub 2019 Mar 7.
|
| 304 |
Overexpression of TRIM24 is correlated with the progression of human cervical cancer.Am J Transl Res. 2017 Feb 15;9(2):620-628. eCollection 2017.
|
| 305 |
TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.Oncol Rep. 2018 Apr;39(4):1860-1866. doi: 10.3892/or.2018.6235. Epub 2018 Jan 26.
|
| 306 |
Knockdown of Tripartite-59 (TRIM59) Inhibits Cellular Proliferation and Migration in Human Cervical Cancer Cells.Oncol Res. 2017 Mar 13;25(3):381-388. doi: 10.3727/096504016X14741511303522. Epub 2016 Sep 22.
|
| 307 |
Analysis of expression and structure of the TSG101 gene in cervical cancer cells.Int J Mol Med. 2010 May;25(5):777-83. doi: 10.3892/ijmm_00000404.
|
| 308 |
TSLP promotes angiogenesis of human umbilical vein endothelial cells by strengthening the crosstalk between cervical cancer cells and eosinophils.Oncol Lett. 2017 Dec;14(6):7483-7488. doi: 10.3892/ol.2017.7121. Epub 2017 Oct 3.
|
| 309 |
UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells.Cell Cycle. 2018;17(3):300-308. doi: 10.1080/15384101.2017.1403686. Epub 2018 Jan 31.
|
| 310 |
Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex.Nat Commun. 2018 Oct 25;9(1):4441. doi: 10.1038/s41467-018-06953-0.
|
| 311 |
Mechanism of the reversal effect of mifepristone on drug resistance of the human cervical cancer cell line HeLa/MMC.Genet Mol Res. 2014 Feb 27;13(1):1288-95. doi: 10.4238/2014.February.27.14.
|
| 312 |
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis.J Clin Invest. 2018 Oct 1;128(10):4280-4296. doi: 10.1172/JCI120518. Epub 2018 Sep 4.
|
| 313 |
Clinical implication of voltage-dependent anion channel 1 in uterine cervical cancer and its action on cervical cancer cells.Oncotarget. 2016 Jan 26;7(4):4210-25. doi: 10.18632/oncotarget.6704.
|
| 314 |
Role of B7-H4 in the Progression and Prognosis of Cervical Inflammation to Cancer After Human Papilloma Virus Infection.J Biomed Nanotechnol. 2019 May 1;15(5):1043-1051. doi: 10.1166/jbn.2019.2741.
|
| 315 |
Wnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer.Int J Clin Exp Pathol. 2014 Aug 15;7(9):6072-8. eCollection 2014.
|
| 316 |
Expression of WNT genes in cervical cancer-derived cells: Implication of WNT7A in cell proliferation and migration.Exp Cell Res. 2015 Jul 1;335(1):39-50. doi: 10.1016/j.yexcr.2015.05.001. Epub 2015 May 12.
|
| 317 |
XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis.Tumour Biol. 2017 Jul;39(7):1010428317717122. doi: 10.1177/1010428317717122.
|
| 318 |
Effect of Ku80 on the radiosensitization of cisplatin in the cervical carcinoma cell line HeLa.Oncol Lett. 2018 Jan;15(1):147-154. doi: 10.3892/ol.2017.7304. Epub 2017 Oct 31.
|
| 319 |
MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.Biochem Biophys Res Commun. 2015 Apr 10;459(3):515-20. doi: 10.1016/j.bbrc.2015.02.138. Epub 2015 Mar 4.
|
| 320 |
MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1.Br J Cancer. 2014 Mar 4;110(5):1260-8. doi: 10.1038/bjc.2013.829. Epub 2014 Jan 14.
|
| 321 |
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.Gynecol Oncol. 2009 Jul;114(1):84-8. doi: 10.1016/j.ygyno.2009.03.017. Epub 2009 Apr 8.
|
| 322 |
Estrogen-related receptor expression and function are associated with vascular endothelial growth factor in human cervical cancer.Int J Gynecol Cancer. 2011 May;21(4):609-15. doi: 10.1097/IGC.0b013e3182017e9b.
|
| 323 |
Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.Gynecol Oncol. 2010 May;117(2):287-90. doi: 10.1016/j.ygyno.2010.01.020. Epub 2010 Feb 16.
|
| 324 |
Transcriptional upregulation of MT2-MMP in response to hypoxia is promoted by HIF-1 in cancer cells.Mol Carcinog. 2011 Oct;50(10):770-80. doi: 10.1002/mc.20678. Epub 2011 Jul 12.
|
| 325 |
The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population.Arch Gynecol Obstet. 2018 May;297(5):1285-1292. doi: 10.1007/s00404-018-4740-6. Epub 2018 Mar 10.
|
| 326 |
The effect of TP53 codon 72 and RNASEL codon 462 polymorphisms on the development of cervical cancer in Argentine women.Cancer Genet. 2011 May;204(5):270-7. doi: 10.1016/j.cancergen.2011.04.001.
|
| 327 |
Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer.J Exp Clin Cancer Res. 2009 Mar 30;28(1):43. doi: 10.1186/1756-9966-28-43.
|
| 328 |
Adeno-associated virus-mediated local delivery of LIGHT suppresses tumorigenesis in a murine cervical cancer model.J Immunother. 2011 Oct;34(8):581-7. doi: 10.1097/CJI.0b013e31822b9fe0.
|
| 329 |
Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer.EXCLI J. 2017 Oct 24;16:1165-1176. doi: 10.17179/excli2017-690. eCollection 2017.
|
| 330 |
Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis.Hum Genet. 2008 Jun;123(5):437-43. doi: 10.1007/s00439-008-0494-8. Epub 2008 Apr 8.
|
| 331 |
Overexpression of riboflavin transporter 2 contributes toward progression and invasion of glioma.Neuroreport. 2016 Oct 19;27(15):1167-73. doi: 10.1097/WNR.0000000000000674.
|
| 332 |
miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.Virol J. 2017 Feb 4;14(1):20. doi: 10.1186/s12985-017-0695-7.
|
| 333 |
Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer.Br J Biomed Sci. 2018 Oct;75(4):169-174. doi: 10.1080/09674845.2018.1482734. Epub 2018 Aug 17.
|
| 334 |
Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer.Gynecol Oncol. 2006 Aug;102(2):173-81. doi: 10.1016/j.ygyno.2005.12.009. Epub 2006 Jan 20.
|
| 335 |
Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.Neoplasma. 2006;53(5):440-3.
|
| 336 |
Analysis of CYP1A1 and COMT polymorphisms in women with cervical cancer.Genet Mol Res. 2015 Dec 29;14(4):18965-73. doi: 10.4238/2015.December.29.3.
|
| 337 |
Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.Cell Death Dis. 2018 Oct 17;9(11):1055. doi: 10.1038/s41419-018-1059-y.
|
| 338 |
N-acetyltransferase 2 gene polymorphism in patients with cervical cancer.Int J Gynecol Cancer. 2009 Oct;19(7):1186-9. doi: 10.1111/IGC.0b013e3181a131b4.
|
| 339 |
Propranolol selectively inhibits cervical cancer cell growth by suppressing the cGMP/PKG pathway.Biomed Pharmacother. 2019 Mar;111:1243-1248. doi: 10.1016/j.biopha.2019.01.027. Epub 2019 Jan 15.
|
| 340 |
Collagen prolyl 4-hydroxylase 2 predicts worse prognosis and promotes glycolysis in cervical cancer.Am J Transl Res. 2019 Nov 15;11(11):6938-6951. eCollection 2019.
|
| 341 |
Fibrates in the chemical action of daunorubicin.Curr Cancer Drug Targets. 2009 May;9(3):366-9. doi: 10.2174/156800909788166538.
|
| 342 |
-Actinin-4 regulates cancer stem cell properties and chemoresistance in cervical cancer.Carcinogenesis. 2020 Jul 14;41(7):940-949. doi: 10.1093/carcin/bgz168.
|
| 343 |
Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1273-1280. doi: 10.1080/21691401.2019.1596922.
|
| 344 |
Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression.Gynecol Oncol. 2007 Feb;104(2):352-61. doi: 10.1016/j.ygyno.2006.08.054. Epub 2006 Nov 13.
|
| 345 |
The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism.Eur J Cancer. 2007 Jul;43(10):1590-5. doi: 10.1016/j.ejca.2007.03.025. Epub 2007 May 18.
|
| 346 |
Ataxin-1 regulates epithelial-mesenchymal transition of cervical cancer cells.Oncotarget. 2017 Mar 14;8(11):18248-18259. doi: 10.18632/oncotarget.15319.
|
| 347 |
Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas.Oncol Rep. 2003 Sep-Oct;10(5):1195-200.
|
| 348 |
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.PLoS One. 2015 Dec 28;10(12):e0144360. doi: 10.1371/journal.pone.0144360. eCollection 2015.
|
| 349 |
B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells.Cancer Lett. 2016 Jun 1;375(2):284-292. doi: 10.1016/j.canlet.2016.03.016. Epub 2016 Mar 14.
|
| 350 |
Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer.Exp Cell Res. 2002 Nov 1;280(2):280-7. doi: 10.1006/excr.2002.5649.
|
| 351 |
CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.J Exp Clin Cancer Res. 2019 Mar 18;38(1):131. doi: 10.1186/s13046-019-1137-8.
|
| 352 |
Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation.Cancer Sci. 2015 Oct;106(10):1333-40. doi: 10.1111/cas.12761. Epub 2015 Sep 25.
|
| 353 |
CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.Virology. 2006 Oct 25;354(2):280-5. doi: 10.1016/j.virol.2006.06.018. Epub 2006 Aug 14.
|
| 354 |
Creatine kinase B is a target molecule of reactive oxygen species in cervical cancer.Mol Cells. 2001 Dec 31;12(3):412-7.
|
| 355 |
Specific detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction of a beta-casein-like protein, preferentially expressed in malignant neoplasms.Anticancer Res. 2001 Jul-Aug;21(4A):2547-51.
|
| 356 |
miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.Chem Biol Interact. 2018 Apr 1;285:85-95. doi: 10.1016/j.cbi.2018.02.024. Epub 2018 Feb 23.
|
| 357 |
NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors.J Biol Chem. 2005 May 20;280(20):20000-9. doi: 10.1074/jbc.M412169200. Epub 2005 Mar 21.
|
| 358 |
FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication.mBio. 2017 Feb 14;8(1):e02340-16. doi: 10.1128/mBio.02340-16.
|
| 359 |
High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer.Cancer Med. 2017 Aug;6(8):1871-1881. doi: 10.1002/cam4.1112. Epub 2017 Jul 18.
|
| 360 |
Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.Cancer Res. 2007 Nov 1;67(21):10163-72. doi: 10.1158/0008-5472.CAN-07-2056.
|
| 361 |
Interferon, alpha 17 (IFNA17) Ile184Arg polymorphism and cervical cancer risk.Cancer Lett. 2003 Jan 28;189(2):183-8. doi: 10.1016/s0304-3835(02)00548-7.
|
| 362 |
Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice.Cancer Res. 1999 Aug 15;59(16):3991-7.
|
| 363 |
Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer.Cancer Res. 2005 Oct 1;65(19):8640-5. doi: 10.1158/0008-5472.CAN-04-4112.
|
| 364 |
Down-regulation of members of glycolipid-enriched membrane raft gene family, MAL and BENE, in cervical squamous cell cancers.J Obstet Gynaecol Res. 2004 Feb;30(1):53-8. doi: 10.1111/j.1341-8076.2004.00156.x.
|
| 365 |
Gene amplification and expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in HPV-infected cervical neoplasias.Anticancer Res. 2001 Jul-Aug;21(4A):2405-11.
|
| 366 |
DNA methylation in serum and tumors of cervical cancer patients.Clin Cancer Res. 2004 Jan 15;10(2):565-71. doi: 10.1158/1078-0432.ccr-0825-03.
|
| 367 |
Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells. Biochem Biophys Res Commun. 2012 Aug 24;425(2):462-7.
|
| 368 |
Malignant transformation of human ectocervical cells immortalized by HPV 18: in vitro model of carcinogenesis by cigarette smoke.Carcinogenesis. 1996 Mar;17(3):577-83. doi: 10.1093/carcin/17.3.577.
|
| 369 |
PTEN and NDUFB8 aberrations in cervical cancer tissue.Adv Exp Med Biol. 2007;599:31-6. doi: 10.1007/978-0-387-71764-7_5.
|
| 370 |
NUMB is a break of WNT-Notch signaling cycle.Int J Mol Med. 2006 Sep;18(3):517-21.
|
| 371 |
The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.EMBO J. 1994 Mar 15;13(6):1460-6. doi: 10.1002/j.1460-2075.1994.tb06400.x.
|
| 372 |
Overexpression of oxidored-nitro domain containing protein 1 induces growth inhibition and apoptosis in human prostate cancer PC3 cells.Oncol Rep. 2014 Nov;32(5):1939-46. doi: 10.3892/or.2014.3407. Epub 2014 Aug 14.
|
| 373 |
Connective tissue activating peptide III expression disappears progressively with increased dysplasia in human cervical epithelium.Gynecol Oncol. 2000 Oct;79(1):23-7. doi: 10.1006/gyno.2000.5915.
|
| 374 |
Sodium butyrate produces concordant expression of "early placental" alkaline phosphatase, pregnancy-specific beta 1-glycoprotein and human chronic gonadotropin beta-subunit in a newly established uterine cervical cancer cell line (SKG-IIIa).Int J Cancer. 1983 Sep 15;32(3):267-72. doi: 10.1002/ijc.2910320302.
|
| 375 |
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15601-6. doi: 10.1073/pnas.2636900100. Epub 2003 Dec 11.
|
| 376 |
Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis.Int J Gynecol Cancer. 2007 May-Jun;17(3):687-96. doi: 10.1111/j.1525-1438.2007.00834.x.
|
| 377 |
C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.Tumour Biol. 2016 Jan;37(1):369-79. doi: 10.1007/s13277-015-3806-3. Epub 2015 Jul 29.
|
| 378 |
Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix.Cancer. 1990 Jul 15;66(2):295-301. doi: 10.1002/1097-0142(19900715)66:2<295::aid-cncr2820660217>3.0.co;2-e.
|
| 379 |
HPV16-transformed human keratinocytes depend on SIX1 expression for proliferation and HPV E6/E7 gene expression.Virology. 2019 Nov;537:20-30. doi: 10.1016/j.virol.2019.08.009. Epub 2019 Aug 13.
|
| 380 |
Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix.Gynecol Oncol. 2001 Oct;83(1):121-7. doi: 10.1006/gyno.2001.6358.
|
| 381 |
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman.Clin Cancer Res. 2002 Feb;8(2):549-54.
|
| 382 |
Methylation in the promoter regions of WT1, NKX6-1 and DBC1 genes in cervical cancer tissues of Uygur women in Xinjiang.Genet Mol Biol. 2018 Jan-Mar;41(1):9-17. doi: 10.1590/1678-4685-GMB-2016-0146.
|
| 383 |
Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.Kaohsiung J Med Sci. 2019 Jun;35(6):332-340. doi: 10.1002/kjm2.12058. Epub 2019 Mar 23.
|
| 384 |
Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development.APMIS. 2009 Jan;117(1):53-9. doi: 10.1111/j.1600-0463.2008.00015.x.
|
| 385 |
Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.Oncol Rep. 2008 May;19(5):1339-45.
|
| 386 |
Association of GSTM1, GSTT1, and GSTM3 gene polymorphisms and susceptibility to cervical cancer in a North Indian population.Am J Obstet Gynecol. 2008 Mar;198(3):303.e1-6. doi: 10.1016/j.ajog.2007.09.046. Epub 2008 Feb 21.
|
| 387 |
Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.J Proteome Res. 2009 Aug;8(8):3969-76. doi: 10.1021/pr900287a.
|
| 388 |
Associations of MICB with cervical cancer in north-eastern Thais: identification of major histocompatibility complex class I chain-related gene B motifs influencing natural killer cell activation.Clin Exp Immunol. 2008 Aug;153(2):205-13. doi: 10.1111/j.1365-2249.2008.03682.x. Epub 2008 May 26.
|
| 389 |
Effect of NBS1 gene polymorphism on the risk of cervix carcinoma in a northern Indian population.Int J Biol Markers. 2008 Jul-Sep;23(3):133-9. doi: 10.1177/172460080802300301.
|
| 390 |
Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings.Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3000-7. doi: 10.1158/1055-9965.EPI-09-0405. Epub 2009 Oct 20.
|
| 391 |
Prognostic significance of HPV physical status and integration sites in cervical cancer.Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):355-60.
|
| 392 |
Tumor-associated alterations in caspase-14 expression in epithelial malignancies.Clin Cancer Res. 2005 Aug 1;11(15):5462-71. doi: 10.1158/1078-0432.CCR-04-2527.
|
| 393 |
Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer.Braz J Med Biol Res. 2017 Nov 13;51(1):e6822. doi: 10.1590/1414-431X20176822.
|
| 394 |
Functional proteomics, human genetics and cancer biology of GIPC family members.Exp Mol Med. 2013 Jun 7;45(6):e26. doi: 10.1038/emm.2013.49.
|
| 395 |
The expression of inhibitor of growth 4 is reduced in cervical cancer tissues.Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3178-85.
|
| 396 |
NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-/TGF-RI/SMADs signaling.Biochem Biophys Res Commun. 2019 Nov 12;519(3):489-496. doi: 10.1016/j.bbrc.2019.08.020. Epub 2019 Sep 14.
|
| 397 |
Expression analysis of ST3GAL4 transcripts in cervical cancer cells.Mol Med Rep. 2018 Jul;18(1):617-621. doi: 10.3892/mmr.2018.8938. Epub 2018 Apr 27.
|
| 398 |
Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.J Exp Clin Cancer Res. 2016 Oct 28;35(1):170. doi: 10.1186/s13046-016-0445-5.
|
| 399 |
Can ABCF2 protein expression predict the prognosis of uterine cancer?.Br J Cancer. 2008 Nov 18;99(10):1651-5. doi: 10.1038/sj.bjc.6604734.
|
| 400 |
Downregulation of ADAMTS18 May Serve as a Poor Prognostic Biomarker for Cervical Cancer Patients.Appl Immunohistochem Mol Morphol. 2018 Oct;26(9):670-675. doi: 10.1097/PAI.0000000000000496.
|
| 401 |
ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.Diagn Pathol. 2017 Jan 21;12(1):12. doi: 10.1186/s13000-017-0600-0.
|
| 402 |
Role of CD97 small isoform in human cervical carcinoma.Int J Exp Pathol. 2019 Feb;100(1):19-24. doi: 10.1111/iep.12303. Epub 2019 Mar 18.
|
| 403 |
Upregulation and hypomethylation of lncRNA AFAP1AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.Oncol Rep. 2019 Apr;41(4):2431-2439. doi: 10.3892/or.2019.7027. Epub 2019 Feb 21.
|
| 404 |
LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.Biomed Pharmacother. 2019 Sep;117:109082. doi: 10.1016/j.biopha.2019.109082. Epub 2019 Jun 15.
|
| 405 |
LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1.Cancer Biol Ther. 2019;20(12):1453-1461. doi: 10.1080/15384047.2019.1647058. Epub 2019 Aug 7.
|
| 406 |
Modeling Dynamic Contrast-Enhanced MRI Data with a Constrained Local AIF.Mol Imaging Biol. 2018 Feb;20(1):150-159. doi: 10.1007/s11307-017-1090-x.
|
| 407 |
Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense.Oncogene. 2018 Sep;37(38):5191-5204. doi: 10.1038/s41388-018-0339-4. Epub 2018 May 29.
|
| 408 |
AJUBA increases the cisplatin resistance through hippo pathway in cervical cancer.Gene. 2018 Feb 20;644:148-154. doi: 10.1016/j.gene.2017.11.017. Epub 2017 Nov 7.
|
| 409 |
AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells.Mol Cell Biochem. 2018 Nov;448(1-2):311-320. doi: 10.1007/s11010-018-3335-7. Epub 2018 Mar 8.
|
| 410 |
The Human Papillomavirus (HPV) E6 Oncoprotein Regulates CD40 Expression via the AT-Hook Transcription Factor AKNA.Cancers (Basel). 2018 Dec 17;10(12):521. doi: 10.3390/cancers10120521.
|
| 411 |
Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population.Oncotarget. 2016 Nov 22;7(47):76647-76655. doi: 10.18632/oncotarget.12299.
|
| 412 |
A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected].J Transl Med. 2015 Aug 5;13:254. doi: 10.1186/s12967-015-0602-1.
|
| 413 |
Expression of Mllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.Int J Oncol. 2012 Jun;40(6):2013-21. doi: 10.3892/ijo.2012.1370. Epub 2012 Feb 14.
|
| 414 |
circAMOTL1 Motivates AMOTL1 Expression to Facilitate Cervical Cancer Growth.Mol Ther Nucleic Acids. 2020 Mar 6;19:50-60. doi: 10.1016/j.omtn.2019.09.022. Epub 2019 Sep 30.
|
| 415 |
API5 induces cisplatin resistance through FGFR signaling in human cancer cells.Exp Mol Med. 2017 Sep 8;49(9):e374. doi: 10.1038/emm.2017.130.
|
| 416 |
miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer.Oncotarget. 2016 Nov 22;7(47):77508-77515. doi: 10.18632/oncotarget.12716.
|
| 417 |
ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines.Onco Targets Ther. 2017 Feb 7;10:691-701. doi: 10.2147/OTT.S112223. eCollection 2017.
|
| 418 |
ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer.Gene. 2019 Apr 15;692:9-16. doi: 10.1016/j.gene.2019.01.004. Epub 2019 Jan 11.
|
| 419 |
Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection.Hum Mol Genet. 2019 Jan 15;28(2):341-348. doi: 10.1093/hmg/ddy390.
|
| 420 |
Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/ATF1 signaling.Int J Biol Macromol. 2019 Jun 1;130:24-33. doi: 10.1016/j.ijbiomac.2019.02.083. Epub 2019 Feb 18.
|
| 421 |
MicroRNA-378 enhances migration and invasion in cervical cancer by directly targeting autophagy-related protein 12.Mol Med Rep. 2018 May;17(5):6319-6326. doi: 10.3892/mmr.2018.8645. Epub 2018 Feb 27.
|
| 422 |
miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.Oncol Res. 2018 Jul 5;26(6):923-931. doi: 10.3727/096504017X15143731031009. Epub 2018 Jan 2.
|
| 423 |
High brain acid soluble protein 1(BASP1) is a poor prognostic factor for cervical cancer and promotes tumor growth.Cancer Cell Int. 2017 Oct 24;17:97. doi: 10.1186/s12935-017-0452-4. eCollection 2017.
|
| 424 |
Inhibition of BAP31 expression inhibits cervical cancer progression by suppressing metastasis and inducing intrinsic and extrinsic apoptosis.Biochem Biophys Res Commun. 2019 Jan 8;508(2):499-506. doi: 10.1016/j.bbrc.2018.11.017. Epub 2018 Nov 30.
|
| 425 |
A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer.Oncotarget. 2017 Jun 13;8(24):39417-39429. doi: 10.18632/oncotarget.17034.
|
| 426 |
Knockdown of BRCC3 exerts an antitumor effect on cervical cancer invitro.Mol Med Rep. 2018 Dec;18(6):4886-4894. doi: 10.3892/mmr.2018.9511. Epub 2018 Sep 26.
|
| 427 |
Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer.Tumour Biol. 2017 Apr;39(4):1010428317697557. doi: 10.1177/1010428317697557.
|
| 428 |
Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.Oncogene. 2018 Sep;37(39):5257-5268. doi: 10.1038/s41388-018-0347-4. Epub 2018 May 31.
|
| 429 |
Characterization of DNA hydroxymethylation profile in cervical cancer.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2706-2714. doi: 10.1080/21691401.2019.1634578.
|
| 430 |
Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers--Hepatocellular Carcinoma and Cervical Cancer.PLoS One. 2015 Jul 6;10(7):e0132352. doi: 10.1371/journal.pone.0132352. eCollection 2015.
|
| 431 |
Analysis of CASP12 diagnostic and prognostic values in cervical cancer based on TCGA database.Biosci Rep. 2019 Dec 20;39(12):BSR20192706. doi: 10.1042/BSR20192706.
|
| 432 |
Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period.Int J Gynecol Cancer. 2018 May;28(4):757-763. doi: 10.1097/IGC.0000000000001228.
|
| 433 |
CircRNA8924 Promotes Cervical Cancer Cell Proliferation, Migration and Invasion by Competitively Binding to MiR-518d-5p /519-5p Family and Modulating the Expression of CBX8.Cell Physiol Biochem. 2018;48(1):173-184. doi: 10.1159/000491716. Epub 2018 Jul 13.
|
| 434 |
Regulatory effects of CCDC3 on proliferation, migration, invasion and EMT of human cervical cancer cells.Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3217-3224. doi: 10.26355/eurrev_201904_17680.
|
| 435 |
High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients.Med Sci Monit. 2018 Nov 20;24:8383-8390. doi: 10.12659/MSM.913346.
|
| 436 |
Tumor-associated macrophages induce lymphangiogenesis in cervical cancer via interaction with tumor cells.APMIS. 2014 Nov;122(11):1059-69. doi: 10.1111/apm.12257. Epub 2014 Apr 4.
|
| 437 |
Increased CCL19 expression is associated with progression in cervical cancer.Oncotarget. 2017 May 18;8(43):73817-73825. doi: 10.18632/oncotarget.17982. eCollection 2017 Sep 26.
|
| 438 |
The clinical and prognostic significance of CCN3 expression in patients with cervical cancer.Adv Clin Exp Med. 2013 Nov-Dec;22(6):839-45.
|
| 439 |
Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.Eur Rev Med Pharmacol Sci. 2015 Dec;19(23):4533-41.
|
| 440 |
Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.Genet Mol Res. 2015 Dec 16;14(4):17059-67. doi: 10.4238/2015.December.16.6.
|
| 441 |
MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.Anticancer Drugs. 2019 Jul;30(6):579-587. doi: 10.1097/CAD.0000000000000743.
|
| 442 |
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.PLoS One. 2015 Sep 15;10(9):e0137397. doi: 10.1371/journal.pone.0137397. eCollection 2015.
|
| 443 |
LncRNA FOXD2-AS1 accelerates the progression of cervical cancer via downregulating CDX1.Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10234-10240. doi: 10.26355/eurrev_201912_19660.
|
| 444 |
CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.Clin Cancer Res. 2010 Dec 1;16(23):5770-80. doi: 10.1158/1078-0432.CCR-10-1025. Epub 2010 Oct 22.
|
| 445 |
Correlation between polymorphisms in microRNA-regulated genes and cervical cancer susceptibility in a Xinjiang Uygur population.Oncotarget. 2017 May 9;8(19):31758-31764. doi: 10.18632/oncotarget.15970.
|
| 446 |
A three-gene novel predictor for improving the prognosis of cervical cancer.Oncol Lett. 2019 Nov;18(5):4907-4915. doi: 10.3892/ol.2019.10815. Epub 2019 Sep 5.
|
| 447 |
Enhanced anticancer effects of a methylation inhibitor by inhibiting a novel DNMT1 target, CEP 131, in cervical cancer.BMB Rep. 2019 May;52(5):342-347. doi: 10.5483/BMBRep.2019.52.5.055.
|
| 448 |
High levels of centrosomal protein 55 expression is associated with poor clinical prognosis in patients with cervical cancer.Oncol Lett. 2018 Jun;15(6):9347-9352. doi: 10.3892/ol.2018.8448. Epub 2018 Apr 10.
|
| 449 |
Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes. Int J Oncol. 2007 Oct;31(4):713-20.
|
| 450 |
Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer.Pathology. 2018 Apr;50(3):293-297. doi: 10.1016/j.pathol.2017.09.015. Epub 2018 Feb 13.
|
| 451 |
Feedback between E2F1 and CIP2A regulated by human papillomavirus E7 in cervical cancer: implications for prognosis.Am J Transl Res. 2017 May 15;9(5):2327-2339. eCollection 2017.
|
| 452 |
Different amplification patterns of 3q26 and 5p15 regions in cervical intraepithelial neoplasia and cervical cancer.Ann Diagn Pathol. 2018 Aug;35:16-20. doi: 10.1016/j.anndiagpath.2018.02.003. Epub 2018 Feb 13.
|
| 453 |
Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer.Neoplasia. 2019 Apr;21(4):353-362. doi: 10.1016/j.neo.2019.01.002. Epub 2019 Mar 8.
|
| 454 |
Overexpression of circular RNA hsa_circ_0001038 promotes cervical cancer cell progression by acting as a ceRNA for miR-337-3p to regulate cyclin-M3 and metastasis-associated in colon cancer 1 expression.Gene. 2020 Apr 5;733:144273. doi: 10.1016/j.gene.2019.144273. Epub 2019 Dec 3.
|
| 455 |
PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.Gynecol Oncol. 2019 Oct;155(1):144-150. doi: 10.1016/j.ygyno.2019.08.010. Epub 2019 Aug 18.
|
| 456 |
CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.Int J Biol Sci. 2019 May 12;15(6):1310-1324. doi: 10.7150/ijbs.32987. eCollection 2019.
|
| 457 |
The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries.Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1500-1510. doi: 10.1158/1055-9965.EPI-16-0787. Epub 2017 Jul 14.
|
| 458 |
CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/catenin signaling pathway.Life Sci. 2018 Aug 15;207:420-427. doi: 10.1016/j.lfs.2018.05.054. Epub 2018 Jun 26.
|
| 459 |
CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.BMC Cancer. 2019 May 27;19(1):499. doi: 10.1186/s12885-019-5671-8.
|
| 460 |
Inhibition of CTHRC-1 by its specific monoclonal antibody attenuates cervical cancer cell metastasis.Biomed Pharmacother. 2019 Feb;110:758-763. doi: 10.1016/j.biopha.2018.12.017. Epub 2018 Dec 13.
|
| 461 |
CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway.J Cell Physiol. 2020 May;235(5):4756-4765. doi: 10.1002/jcp.29353. Epub 2019 Oct 30.
|
| 462 |
MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6.Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):1957-1968. doi: 10.26355/eurrev_201903_17234.
|
| 463 |
CYB5D2 displays tumor suppression activities towards cervical cancer.Biochim Biophys Acta. 2016 Apr;1862(4):556-565. doi: 10.1016/j.bbadis.2015.12.013. Epub 2015 Dec 12.
|
| 464 |
The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible epistatic interaction in cervical cancer.Tumour Biol. 2015 Feb;36(2):909-14. doi: 10.1007/s13277-014-2714-2. Epub 2014 Oct 12.
|
| 465 |
Identification of DAPK1 Promoter Hypermethylation as a Biomarker for Intra-Epithelial Lesion and Cervical Cancer: A Meta-Analysis of Published Studies, TCGA, and GEO Datasets.Front Genet. 2018 Jul 17;9:258. doi: 10.3389/fgene.2018.00258. eCollection 2018.
|
| 466 |
MicroRNA?95 inhibits cell proliferation, migration and invasion by targeting defective in cullin neddylation1 domain containing 1 in cervical cancer.Int J Mol Med. 2018 Aug;42(2):779-788. doi: 10.3892/ijmm.2018.3660. Epub 2018 May 8.
|
| 467 |
Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.Int J Gynecol Cancer. 2017 May;27(4):634-642. doi: 10.1097/IGC.0000000000000951.
|
| 468 |
Role of DDX53 in taxol-resistance of cervix cancer cells invitro.Biochem Biophys Res Commun. 2018 Nov 30;506(3):641-647. doi: 10.1016/j.bbrc.2018.10.145. Epub 2018 Oct 26.
|
| 469 |
Human beta-defensin 3 contributes to the carcinogenesis of cervical cancer via activation of NF-B signaling.Oncotarget. 2016 Nov 15;7(46):75902-75913. doi: 10.18632/oncotarget.12426.
|
| 470 |
Copy number variation of the antimicrobial-gene, defensin beta 4, is associated with susceptibility to cervical cancer.J Hum Genet. 2013 May;58(5):250-3. doi: 10.1038/jhg.2013.7. Epub 2013 Mar 7.
|
| 471 |
A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer.Cell Death Differ. 2019 Sep;26(9):1750-1765. doi: 10.1038/s41418-018-0242-0. Epub 2018 Dec 5.
|
| 472 |
Tazarotene-Induced Gene 1 Interacts with DNAJC8 and Regulates Glycolysis in Cervical Cancer Cells.Mol Cells. 2018 Jun;41(6):562-574. doi: 10.14348/molcells.2018.2347. Epub 2018 Jun 14.
|
| 473 |
OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.Oncol Lett. 2017 May;13(5):2929-2936. doi: 10.3892/ol.2017.5848. Epub 2017 Mar 13.
|
| 474 |
Upregulation and overexpression of DVL1, the human counterpart of the Drosophila dishevelled gene, in prostate cancer.Tumori. 2005 Nov-Dec;91(6):546-51. doi: 10.1177/030089160509100616.
|
| 475 |
MiR-486-3p targeting ECM1 represses cell proliferation and metastasis in cervical cancer.Biomed Pharmacother. 2016 May;80:109-114. doi: 10.1016/j.biopha.2016.02.019. Epub 2016 Mar 18.
|
| 476 |
Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.Sci Rep. 2018 Jul 13;8(1):10594. doi: 10.1038/s41598-018-28906-9.
|
| 477 |
Overexpression of fibulin-4 is associated with tumor progression and poor prognosis in patients with cervical carcinoma.Oncol Rep. 2014 Jun;31(6):2601-10. doi: 10.3892/or.2014.3139. Epub 2014 Apr 16.
|
| 478 |
XRCC1 mediated the development of cervival cancer through a novel Sp1/Krox-20 swich.Oncotarget. 2017 Sep 16;8(49):86217-86226. doi: 10.18632/oncotarget.21040. eCollection 2017 Oct 17.
|
| 479 |
eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.Oncotarget. 2016 Apr 5;7(14):18541-57. doi: 10.18632/oncotarget.8105.
|
| 480 |
Downregulation of eukaryotic initiation factor 4A1 improves radiosensitivity by delaying DNA double strand break repair in cervical cancer.Oncol Lett. 2017 Dec;14(6):6976-6982. doi: 10.3892/ol.2017.7040. Epub 2017 Sep 25.
|
| 481 |
MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.Int J Med Sci. 2018 Jan 1;15(2):142-152. doi: 10.7150/ijms.21645. eCollection 2018.
|
| 482 |
circEIF4G2 modulates the malignant features of cervical cancer via the miR?18/HOXA1 pathway.Mol Med Rep. 2019 May;19(5):3714-3722. doi: 10.3892/mmr.2019.10032. Epub 2019 Mar 14.
|
| 483 |
LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression.Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7295-7306. doi: 10.26355/eurrev_201909_18834.
|
| 484 |
Expression levels and roles of EMC-6, Beclin1, and Rab5a in the cervical cancer.Eur Rev Med Pharmacol Sci. 2017 Jul;21(13):3038-3046.
|
| 485 |
Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix.Mol Cell Biochem. 2013 May;377(1-2):45-53. doi: 10.1007/s11010-013-1569-y. Epub 2013 Feb 23.
|
| 486 |
Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1 and protein disulfide isomerase suppresses the progression of cervical cancer.EBioMedicine. 2019 Mar;41:408-419. doi: 10.1016/j.ebiom.2019.02.041. Epub 2019 Feb 27.
|
| 487 |
Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis.Yonsei Med J. 2019 Jul;60(7):611-618. doi: 10.3349/ymj.2019.60.7.611.
|
| 488 |
Fructose?,6bisphosphatase? decrease may promote carcinogenesis and chemoresistance in cervical cancer.Mol Med Rep. 2017 Dec;16(6):8563-8571. doi: 10.3892/mmr.2017.7665. Epub 2017 Sep 29.
|
| 489 |
F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.Biomed Pharmacother. 2018 Nov;107:1712-1719. doi: 10.1016/j.biopha.2018.08.119. Epub 2018 Sep 8.
|
| 490 |
The long noncoding RNA PCGEM1 promotes cell proliferation, migration and invasion via targeting the miR-182/FBXW11 axis in cervical cancer.Cancer Cell Int. 2019 Nov 20;19:304. doi: 10.1186/s12935-019-1030-8. eCollection 2019.
|
| 491 |
FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells.Cancer Med. 2019 Dec;8(18):7774-7780. doi: 10.1002/cam4.2615. Epub 2019 Oct 31.
|
| 492 |
FEZF1 is an Independent Predictive Factor for Recurrence and Promotes Cell Proliferation and Migration in Cervical Cancer.J Cancer. 2018 Oct 10;9(21):3929-3938. doi: 10.7150/jca.26073. eCollection 2018.
|
| 493 |
Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.Gene. 2018 Aug 30;669:99-106. doi: 10.1016/j.gene.2018.05.087. Epub 2018 May 23.
|
| 494 |
Inhibitory effects of FKBP14 on human cervical cancer cells.Mol Med Rep. 2017 Oct;16(4):4265-4272. doi: 10.3892/mmr.2017.7043. Epub 2017 Jul 21.
|
| 495 |
Common filaggrin gene mutations and risk of cervical cancer.Acta Oncol. 2015 Feb;54(2):217-23. doi: 10.3109/0284186X.2014.973613. Epub 2014 Nov 10.
|
| 496 |
Genetic variants in TAP are associated with high-grade cervical neoplasia.Clin Cancer Res. 2009 Feb 1;15(3):1019-23. doi: 10.1158/1078-0432.CCR-08-1207.
|
| 497 |
A novel therapeutic vaccine composed of a rearranged human papillomavirus type 16 E6/E7 fusion protein and Fms-like tyrosine kinase-3 ligand induces CD8(+) T cell responses and antitumor effect.Vaccine. 2017 Nov 7;35(47):6459-6467. doi: 10.1016/j.vaccine.2017.09.003. Epub 2017 Oct 10.
|
| 498 |
microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2.Arch Biochem Biophys. 2018 Nov 1;657:23-30. doi: 10.1016/j.abb.2018.09.008. Epub 2018 Sep 14.
|
| 499 |
SP1-mediated long noncoding RNA POU3F3 accelerates the cervical cancer through miR-127-5p/FOXD1.Biomed Pharmacother. 2019 Sep;117:109133. doi: 10.1016/j.biopha.2019.109133. Epub 2019 Jun 25.
|
| 500 |
FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway.Biosci Rep. 2018 Oct 17;38(5):BSR20180747. doi: 10.1042/BSR20180747. Print 2018 Oct 31.
|
| 501 |
MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.Biomed Pharmacother. 2016 Apr;79:294-301. doi: 10.1016/j.biopha.2016.02.033. Epub 2016 Mar 14.
|
| 502 |
FOXL2 suppresses proliferation, invasion and promotes apoptosis of cervical cancer cells.Int J Clin Exp Pathol. 2014 Mar 15;7(4):1534-43. eCollection 2014.
|
| 503 |
Long non-coding RNA MIR205HG function as a ceRNA to accelerate tumor growth and progression via sponging miR-122-5p in cervical cancer.Biochem Biophys Res Commun. 2019 Jun 18;514(1):78-85. doi: 10.1016/j.bbrc.2019.04.102. Epub 2019 Apr 22.
|
| 504 |
FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer.Int J Oncol. 2001 Aug;19(2):311-5. doi: 10.3892/ijo.19.2.311.
|
| 505 |
Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.Biomed Pharmacother. 2016 Dec;84:270-276. doi: 10.1016/j.biopha.2016.09.042. Epub 2016 Sep 22.
|
| 506 |
Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.Sci Rep. 2019 Jul 5;9(1):9729. doi: 10.1038/s41598-019-46077-z.
|
| 507 |
Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.Biomed Pharmacother. 2018 Oct;106:1454-1460. doi: 10.1016/j.biopha.2018.07.101. Epub 2018 Jul 24.
|
| 508 |
Gfi-1 promotes proliferation of human cervical carcinoma via targeting of FBW7 ubiquitin ligase expression.Cancer Manag Res. 2018 Aug 23;10:2849-2857. doi: 10.2147/CMAR.S161130. eCollection 2018.
|
| 509 |
GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.Oncol Rep. 2017 May;37(5):2652-2662. doi: 10.3892/or.2017.5573. Epub 2017 Apr 11.
|
| 510 |
miRNA-218 regulates the proliferation and apoptosis of cervical cancer cells via targeting Gli3.Exp Ther Med. 2018 Sep;16(3):2433-2441. doi: 10.3892/etm.2018.6491. Epub 2018 Jul 20.
|
| 511 |
MicroRNA-143 regulates cell migration and invasion by targeting GOLM1 in cervical cancer.Oncol Lett. 2018 Nov;16(5):6393-6400. doi: 10.3892/ol.2018.9441. Epub 2018 Sep 17.
|
| 512 |
Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers.PLoS One. 2016 Sep 9;11(9):e0162623. doi: 10.1371/journal.pone.0162623. eCollection 2016.
|
| 513 |
Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.Int J Cancer. 2018 Mar 1;142(5):1056-1066. doi: 10.1002/ijc.31124. Epub 2017 Oct 31.
|
| 514 |
GPX2 suppression of H(2)O(2) stress regulates cervical cancer metastasis and apoptosis via activation of the -catenin-WNT pathway.Onco Targets Ther. 2019 Aug 19;12:6639-6651. doi: 10.2147/OTT.S208781. eCollection 2019.
|
| 515 |
Grb7 is over-expressed in cervical cancer and facilitate invasion and inhibit apoptosis in cervical cancer cells.Pathol Res Pract. 2017 Sep;213(9):1180-1184. doi: 10.1016/j.prp.2017.05.013. Epub 2017 Jul 26.
|
| 516 |
Analysis of rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and its Impact on Gasdermin B Expression.Mol Diagn Ther. 2017 Apr;21(2):199-207. doi: 10.1007/s40291-017-0256-1.
|
| 517 |
O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.Oncotarget. 2016 Jul 12;7(28):44596-44607. doi: 10.18632/oncotarget.10112.
|
| 518 |
Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.Pathol Res Pract. 2018 Sep;214(9):1340-1344. doi: 10.1016/j.prp.2017.07.031. Epub 2017 Aug 1.
|
| 519 |
LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4812-4819. doi: 10.26355/eurrev_201808_15616.
|
| 520 |
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.Gynecol Oncol. 2009 Feb;112(2):293-9. doi: 10.1016/j.ygyno.2008.10.012. Epub 2008 Dec 2.
|
| 521 |
Sipi soup inhibits cancerassociated fibroblast activation and the inflammatory process by downregulating long noncoding RNA HIPK1AS.Mol Med Rep. 2018 Aug;18(2):1361-1368. doi: 10.3892/mmr.2018.9144. Epub 2018 Jun 6.
|
| 522 |
Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.Int Immunopharmacol. 2014 Jan;18(1):71-6. doi: 10.1016/j.intimp.2013.10.018. Epub 2013 Nov 4.
|
| 523 |
Association between HLA-DP Gene Polymorphisms and Cervical Cancer Risk: A Meta-Analysis.Biomed Res Int. 2018 Jun 13;2018:7301595. doi: 10.1155/2018/7301595. eCollection 2018.
|
| 524 |
Protective association of HLA-DRB1*13:02, HLA-DRB1*04:06, and HLA-DQB1*06:04 alleles with cervical cancer in a Korean population.Hum Immunol. 2019 Feb;80(2):107-111. doi: 10.1016/j.humimm.2018.10.013. Epub 2018 Oct 21.
|
| 525 |
Is there a role played by HLA-E, if any, in HPV immune evasion?.Scand J Immunol. 2020 Mar;91(3):e12850. doi: 10.1111/sji.12850. Epub 2019 Dec 10.
|
| 526 |
Knockdown of homeobox containing 1 increases the radiosensitivity of cervical cancer cells through telomere shortening.Oncol Rep. 2017 Jul;38(1):515-521. doi: 10.3892/or.2017.5707. Epub 2017 Jun 6.
|
| 527 |
MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/-catenin signaling pathway.Oncol Lett. 2019 Aug;18(2):1786-1792. doi: 10.3892/ol.2019.10470. Epub 2019 Jun 12.
|
| 528 |
A case of cervical cancer expressed three mRNA variant of Hyaluronan-mediated motility receptor.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2256-64. eCollection 2014.
|
| 529 |
HOXA9 is Underexpressed in Cervical Cancer Cells and its Restoration Decreases Proliferation, Migration and Expression of Epithelial-to-Mesenchymal Transition Genes.Asian Pac J Cancer Prev. 2016;17(3):1037-47. doi: 10.7314/apjcp.2016.17.3.1037.
|
| 530 |
MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8.Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):87-95. doi: 10.26355/eurrev_201901_16752.
|
| 531 |
HOXC6 promotes cervical cancer progression via regulation of Bcl-2.FASEB J. 2019 Mar;33(3):3901-3911. doi: 10.1096/fj.201801099RR. Epub 2018 Dec 3.
|
| 532 |
Upregulated expression of HOXC8 is associated with poor prognosis of cervical cancer.Oncol Lett. 2018 May;15(5):7291-7296. doi: 10.3892/ol.2018.8200. Epub 2018 Mar 7.
|
| 533 |
Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.Gynecol Oncol. 2019 Nov;155(2):340-348. doi: 10.1016/j.ygyno.2019.08.026. Epub 2019 Aug 30.
|
| 534 |
Methylation in the promoters of HS3ST2 and CCNA1 genes is associated with cervical cancer in Uygur women in Xinjiang.Int J Biol Markers. 2014 Dec 9;29(4):e354-62. doi: 10.5301/jbm.5000107.
|
| 535 |
Role of Smac, survivin, XIAP, and Omi/HtrA2 proteins in determining the chemotherapeutic response of patients with cervical cancer treated with neoadjuvant chemotherapy.Cancer Biomark. 2019;26(3):249-259. doi: 10.3233/CBM-182165.
|
| 536 |
Overexpression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related protein in cervical cancer and correlation with squamous cell carcinoma antigen.Oncol Lett. 2017 Sep;14(3):2813-2821. doi: 10.3892/ol.2017.6508. Epub 2017 Jun 30.
|
| 537 |
Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.Biomed Pharmacother. 2018 Mar;99:169-175. doi: 10.1016/j.biopha.2018.01.048. Epub 2018 Jan 11.
|
| 538 |
Exploration of the molecular mechanisms of cervical cancer based on mRNA expression profiles and predicted microRNA interactions.Oncol Lett. 2018 Jun;15(6):8965-8972. doi: 10.3892/ol.2018.8494. Epub 2018 Apr 13.
|
| 539 |
LncRNA GAS5 confers the radio sensitivity of cervical cancer cells via regulating miR-106b/IER3 axis.Int J Biol Macromol. 2019 Apr 1;126:994-1001. doi: 10.1016/j.ijbiomac.2018.12.176. Epub 2018 Dec 20.
|
| 540 |
IER5 as a promising predictive marker promotes irradiation-induced apoptosis in cervical cancer tissues from patients undergoing chemoradiotherapy.Oncotarget. 2017 May 30;8(22):36438-36448. doi: 10.18632/oncotarget.16857.
|
| 541 |
Down-regulation of IFITM1 and its growth inhibitory role in cervical squamous cell carcinoma.Cancer Cell Int. 2017 Oct 10;17:88. doi: 10.1186/s12935-017-0456-0. eCollection 2017.
|
| 542 |
MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis.Oncotarget. 2016 Oct 18;7(42):68397-68411. doi: 10.18632/oncotarget.11722.
|
| 543 |
Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression.Oncotarget. 2016 Nov 1;7(44):72250-72262. doi: 10.18632/oncotarget.12667.
|
| 544 |
INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.J Cell Mol Med. 2018 May;22(5):2935-2943. doi: 10.1111/jcmm.13595. Epub 2018 Mar 7.
|
| 545 |
miR-181a-5p Promotes Proliferation and Invasion and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A).Oncol Res. 2018 Jun 11;26(5):703-712. doi: 10.3727/096504017X14982569377511. Epub 2017 Jun 23.
|
| 546 |
Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1.PLoS Pathog. 2018 Aug 8;14(8):e1007158. doi: 10.1371/journal.ppat.1007158. eCollection 2018 Aug.
|
| 547 |
Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.Mol Carcinog. 2017 Jun;56(6):1578-1589. doi: 10.1002/mc.22613. Epub 2017 Mar 6.
|
| 548 |
MicroRNA-26b acts as an antioncogene and prognostic factor in cervical cancer.Oncol Lett. 2019 Mar;17(3):3418-3424. doi: 10.3892/ol.2019.9965. Epub 2019 Jan 24.
|
| 549 |
MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.J Cell Physiol. 2018 Sep;233(9):7379-7390. doi: 10.1002/jcp.26574. Epub 2018 Mar 25.
|
| 550 |
Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells.Nutr Cancer. 2013;65 Suppl 1:88-97. doi: 10.1080/01635581.2013.785008.
|
| 551 |
The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1.J Cell Mol Med. 2018 Nov;22(11):5333-5345. doi: 10.1111/jcmm.13806. Epub 2018 Aug 6.
|
| 552 |
Upregulated circ_0005576 facilitates cervical cancer progression via the miR-153/KIF20A axis.Biomed Pharmacother. 2019 Oct;118:109311. doi: 10.1016/j.biopha.2019.109311. Epub 2019 Aug 10.
|
| 553 |
Elevated Expression of Kin17 in Cervical Cancer and Its Association With Cancer Cell Proliferation and Invasion.Int J Gynecol Cancer. 2017 May;27(4):628-633. doi: 10.1097/IGC.0000000000000928.
|
| 554 |
SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy.Biochem Biophys Res Commun. 2019 Aug 27;516(3):619-625. doi: 10.1016/j.bbrc.2019.06.058. Epub 2019 Jun 22.
|
| 555 |
Downregulation of Krppellike factor 1 inhibits the metastasis and invasion of cervical cancer cells.Mol Med Rep. 2018 Oct;18(4):3932-3940. doi: 10.3892/mmr.2018.9401. Epub 2018 Aug 20.
|
| 556 |
Krppel-Like Factor 10 participates in cervical cancer immunoediting through transcriptional regulation of Pregnancy-Specific Beta-1 Glycoproteins.Sci Rep. 2018 Jun 21;8(1):9445. doi: 10.1038/s41598-018-27711-8.
|
| 557 |
KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8.Oncogene. 2016 Oct 20;35(42):5565-5575. doi: 10.1038/onc.2016.97. Epub 2016 Apr 4.
|
| 558 |
MicroRNA-152 Acts as a Tumor Suppressor MicroRNA by Inhibiting Krppel-Like Factor 5 in Human Cervical Cancer.Oncol Res. 2019 Feb 21;27(3):335-340. doi: 10.3727/096504018X15252202178408. Epub 2018 Aug 21.
|
| 559 |
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.Biochem Biophys Res Commun. 2018 Sep 5;503(2):556-563. doi: 10.1016/j.bbrc.2018.05.165. Epub 2018 Aug 2.
|
| 560 |
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.BMC Cancer. 2017 Apr 8;17(1):252. doi: 10.1186/s12885-017-3257-x.
|
| 561 |
HBXIP over expression as an independent biomarker for cervical cancer.Exp Mol Pathol. 2017 Feb;102(1):133-137. doi: 10.1016/j.yexmp.2017.01.009. Epub 2017 Jan 16.
|
| 562 |
LATS1 suppresses proliferation and invasion of cervical cancer.Mol Med Rep. 2017 Apr;15(4):1654-1660. doi: 10.3892/mmr.2017.6180. Epub 2017 Feb 8.
|
| 563 |
Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression.Oncol Res. 2014;22(5-6):301-9. doi: 10.3727/096504015X14424348425991.
|
| 564 |
Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.Cancer Res. 2008 Apr 1;68(7):2489-97. doi: 10.1158/0008-5472.CAN-07-3194.
|
| 565 |
Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT.Biochem Biophys Res Commun. 2018 Sep 5;503(2):1108-1114. doi: 10.1016/j.bbrc.2018.06.127. Epub 2018 Aug 2.
|
| 566 |
Detection of hypermethylated genes as markers for cervical screening in women living with HIV.J Int AIDS Soc. 2018 Aug;21(8):e25165. doi: 10.1002/jia2.25165.
|
| 567 |
Deregulation of LIMD1-VHL-HIF-1-VEGF pathway is associated with different stages of cervical cancer.Biochem J. 2018 May 31;475(10):1793-1806. doi: 10.1042/BCJ20170649.
|
| 568 |
Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.Gynecol Oncol. 2018 Sep;150(3):545-551. doi: 10.1016/j.ygyno.2018.06.014. Epub 2018 Jun 28.
|
| 569 |
Lon Peptidase 2, Peroxisomal (LONP2) Contributes to Cervical Carcinogenesis via Oxidative Stress.Med Sci Monit. 2018 Mar 4;24:1310-1320. doi: 10.12659/msm.908966.
|
| 570 |
LINC00958 facilitates cervical cancer cell proliferation and metastasis by sponging miR-625-5p to upregulate LRRC8E expression.J Cell Biochem. 2020 Mar;121(3):2500-2509. doi: 10.1002/jcb.29472. Epub 2019 Nov 5.
|
| 571 |
Anti-Cancerous Potential of Polysaccharide Fractions Extracted from Peony Seed Dreg on Various Human Cancer Cell Lines Via Cell Cycle Arrest and Apoptosis.Front Pharmacol. 2017 Mar 3;8:102. doi: 10.3389/fphar.2017.00102. eCollection 2017.
|
| 572 |
Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.Oncotarget. 2014 Nov 15;5(21):10870-85. doi: 10.18632/oncotarget.2539.
|
| 573 |
miR-214 down-regulates MKK3 and suppresses malignant phenotypes of cervical cancer cells.Gene. 2020 Jan 15;724:144146. doi: 10.1016/j.gene.2019.144146. Epub 2019 Oct 18.
|
| 574 |
MiR-144-3p: a novel tumor suppressor targeting MAPK6 in cervical cancer.J Physiol Biochem. 2019 Jun;75(2):143-152. doi: 10.1007/s13105-019-00681-9. Epub 2019 Apr 23.
|
| 575 |
E6-induced selective translation of WNT4 and JIP2 promotes the progression of cervical cancer via a noncanonical WNT signaling pathway.Signal Transduct Target Ther. 2019 Sep 13;4:32. doi: 10.1038/s41392-019-0060-y. eCollection 2019.
|
| 576 |
The possible association between the presence of an MPO -463 G?A (rs2333227) polymorphism and cervical cancer risk.Pathol Res Pract. 2018 Aug;214(8):1142-1148. doi: 10.1016/j.prp.2018.05.018. Epub 2018 May 22.
|
| 577 |
Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.BMC Health Serv Res. 2019 Nov 19;19(1):847. doi: 10.1186/s12913-019-4718-5.
|
| 578 |
Ubiquitin E3 Ligase MARCH7 promotes proliferation and invasion of cervical cancer cells through VAV2-RAC1-CDC42 pathway.Oncol Lett. 2018 Aug;16(2):2312-2318. doi: 10.3892/ol.2018.8908. Epub 2018 Jun 5.
|
| 579 |
GRSF1-mediated MIR-G-1 promotes malignant behavior and nuclear autophagy by directly upregulating TMED5 and LMNB1 in cervical cancer cells.Autophagy. 2019 Apr;15(4):668-685. doi: 10.1080/15548627.2018.1539590. Epub 2018 Nov 5.
|
| 580 |
Expression levels of resistant genes affect cervical cancer prognosis.Mol Med Rep. 2017 May;15(5):2802-2806. doi: 10.3892/mmr.2017.6328. Epub 2017 Mar 15.
|
| 581 |
MBNL1 regulates resistance of HeLa cells to cisplatin via Nrf2.Biochem Biophys Res Commun. 2020 Feb 12;522(3):763-769. doi: 10.1016/j.bbrc.2019.11.162. Epub 2019 Nov 29.
|
| 582 |
Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling.Onco Targets Ther. 2018 Jun 6;11:3323-3333. doi: 10.2147/OTT.S157025. eCollection 2018.
|
| 583 |
Correlation of MCM2 detection with stage and virology of cervical cancer.Int J Biol Markers. 2014 Dec 9;29(4):e363-71. doi: 10.5301/jbm.5000081.
|
| 584 |
HPV-type-specific response of cervical cancer cells to cisplatin after silencing replication licensing factor MCM4.Tumour Biol. 2015 Dec;36(12):9987-94. doi: 10.1007/s13277-015-3782-7. Epub 2015 Jul 19.
|
| 585 |
The role of MCM5 expression in cervical cancer: Correlation with progression and prognosis.Biomed Pharmacother. 2018 Feb;98:165-172. doi: 10.1016/j.biopha.2017.12.006. Epub 2017 Dec 27.
|
| 586 |
STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.Tumour Biol. 2016 Apr;37(4):5385-95. doi: 10.1007/s13277-015-4385-z. Epub 2015 Nov 12.
|
| 587 |
Role and mechanism of miR-4778-3p and its targets NR2C2 and Med19 in cervical cancer radioresistance.Biochem Biophys Res Commun. 2019 Jan 1;508(1):210-216. doi: 10.1016/j.bbrc.2018.11.110. Epub 2018 Nov 23.
|
| 588 |
Downregulation of miR-30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.Oncol Lett. 2017 Dec;14(6):7437-7442. doi: 10.3892/ol.2017.7114. Epub 2017 Oct 2.
|
| 589 |
Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer.Exp Ther Med. 2017 Oct;14(4):2789-2794. doi: 10.3892/etm.2017.4887. Epub 2017 Aug 4.
|
| 590 |
PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.Clin Transl Oncol. 2014 Mar;16(3):266-72. doi: 10.1007/s12094-013-1067-4. Epub 2013 Jun 18.
|
| 591 |
MFAP5 suppression inhibits migration/invasion, regulates cell cycle and induces apoptosis via promoting ROS production in cervical cancer.Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):51-58. doi: 10.1016/j.bbrc.2018.10.146. Epub 2018 Nov 16.
|
| 592 |
Decreased expression of aquaporin 1 correlates with clinicopathological features of patients with cervical cancer.Onco Targets Ther. 2019 Apr 23;12:2843-2851. doi: 10.2147/OTT.S194650. eCollection 2019.
|
| 593 |
TXNIP induced by MondoA, rather than ChREBP, suppresses cervical cancer cell proliferation, migration and invasion.J Biochem. 2020 Apr 1;167(4):371-377. doi: 10.1093/jb/mvz105.
|
| 594 |
Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments.J Natl Cancer Inst. 2002 Jul 17;94(14):1071-9. doi: 10.1093/jnci/94.14.1071.
|
| 595 |
Motor Neuron and Pancreas Homeobox 1 (MNX1) Is Involved in Promoting Squamous Cervical Cancer Proliferation via Regulating Cyclin E.Med Sci Monit. 2019 Aug 22;25:6304-6312. doi: 10.12659/MSM.914233.
|
| 596 |
MicroRNA-543 acts as a prognostic marker and promotes the cell proliferation in cervical cancer by BRCA1-interacting protein 1.Tumour Biol. 2017 Feb;39(2):1010428317691187. doi: 10.1177/1010428317691187.
|
| 597 |
LncRNA HOTAIR promotes cell migration and invasion by regulating MKL1 via inhibition miR206 expression in HeLa cells.Cell Commun Signal. 2018 Feb 1;16(1):5. doi: 10.1186/s12964-018-0216-3.
|
| 598 |
MSX1 induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer.Onco Targets Ther. 2018 Aug 10;11:4769-4780. doi: 10.2147/OTT.S165144. eCollection 2018.
|
| 599 |
MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4.Biochem Biophys Res Commun. 2017 Apr 1;485(2):556-562. doi: 10.1016/j.bbrc.2016.12.020. Epub 2016 Dec 5.
|
| 600 |
circ-MYBL2 Serves As A Sponge For miR-361-3p Promoting Cervical Cancer Cells Proliferation And Invasion.Onco Targets Ther. 2019 Nov 20;12:9957-9964. doi: 10.2147/OTT.S218976. eCollection 2019.
|
| 601 |
The Bidirectional Regulation between MYL5 and HIF-1 Promotes Cervical Carcinoma Metastasis.Theranostics. 2017 Aug 23;7(15):3768-3780. doi: 10.7150/thno.20796. eCollection 2017.
|
| 602 |
Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.Gynecol Oncol. 2018 Apr;149(1):188-197. doi: 10.1016/j.ygyno.2018.01.024. Epub 2018 Feb 1.
|
| 603 |
The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses.Oncogene. 2018 Nov;37(48):6275-6284. doi: 10.1038/s41388-018-0398-6. Epub 2018 Jul 17.
|
| 604 |
Tumor-Suppressor Gene NBPF1 Inhibits Invasion and PI3K/mTOR Signaling in Cervical Cancer Cells.Oncol Res. 2016 Jan 21;23(1-2):13-20. doi: 10.3727/096504015X14410238486766.
|
| 605 |
Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway.J Cell Biochem. 2019 Apr;120(4):6237-6249. doi: 10.1002/jcb.27911. Epub 2018 Oct 18.
|
| 606 |
Long noncoding RNA BDNF-AS is downregulated in cervical cancer and has anti-cancer functions by negatively associating with BDNF.Arch Biochem Biophys. 2018 May 15;646:113-119. doi: 10.1016/j.abb.2018.03.023. Epub 2018 Mar 21.
|
| 607 |
Knockdown of LASP2 inhibits the proliferation, migration, and invasion of cervical cancer cells.J Cell Biochem. 2019 Sep;120(9):15389-15396. doi: 10.1002/jcb.28806. Epub 2019 Apr 26.
|
| 608 |
NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.Cancer Lett. 2019 May 1;449:106-113. doi: 10.1016/j.canlet.2019.02.024. Epub 2019 Feb 16.
|
| 609 |
Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.Int J Gynecol Pathol. 2012 Jan;31(1):15-24. doi: 10.1097/PGP.0b013e318220ba16.
|
| 610 |
The protein interacting with carboxyl terminus-1 codon 389 polymorphism impairs protein interacting with carboxyl terminus-1 function and is a risk factor for uterine cervical cancer.Mol Carcinog. 2017 May;56(5):1484-1492. doi: 10.1002/mc.22608. Epub 2017 Jan 23.
|
| 611 |
NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.Int J Mol Sci. 2016 Oct 20;17(10):1694. doi: 10.3390/ijms17101694.
|
| 612 |
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.Oncotarget. 2017 Oct 31;8(62):105356-105371. doi: 10.18632/oncotarget.22187. eCollection 2017 Dec 1.
|
| 613 |
Nucleoporin 107 Promotes the Survival of Tumor Cells in Cervical Cancers.Gynecol Obstet Invest. 2020;85(1):41-52. doi: 10.1159/000502788. Epub 2019 Sep 5.
|
| 614 |
Expression of Nup93 is associated with the proliferation, migration and invasion capacity of cervical cancer cells.Acta Biochim Biophys Sin (Shanghai). 2019 Dec 13;51(12):1276-1285. doi: 10.1093/abbs/gmz131.
|
| 615 |
Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/-catenin signaling.J Exp Clin Cancer Res. 2019 Jan 24;38(1):33. doi: 10.1186/s13046-019-1037-y.
|
| 616 |
Measles virus phosphoprotein inhibits apoptosis and enhances clonogenic and migratory properties in HeLa cells.J Biosci. 2019 Mar;44(1):10.
|
| 617 |
Occludin protein expression in human cervical cancer and its association with patient's clinical characteristics.J Cancer Res Ther. 2018 Jan;14(1):124-127. doi: 10.4103/jcrt.JCRT_664_17.
|
| 618 |
Effect of Deubiquitinase Ovarian Tumor Domain-Containing Protein 5 (OTUD5) on Radiosensitivity of Cervical Cancer by Regulating the Ubiquitination of Akt and its Mechanism.Med Sci Monit. 2019 May 10;25:3469-3475. doi: 10.12659/MSM.912904.
|
| 619 |
PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.Cell Death Differ. 2019 Jun;26(6):994-1006. doi: 10.1038/s41418-018-0178-4. Epub 2018 Aug 6.
|
| 620 |
Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.Gene. 2020 Jan 10;723:144142. doi: 10.1016/j.gene.2019.144142. Epub 2019 Oct 4.
|
| 621 |
Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer.Mol Genet Genomics. 2016 Aug;291(4):1743-8. doi: 10.1007/s00438-016-1217-9. Epub 2016 May 25.
|
| 622 |
PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer.Onco Targets Ther. 2017 Nov 27;10:5685-5694. doi: 10.2147/OTT.S150139. eCollection 2017.
|
| 623 |
A Lipophilic IR-780 Dye-Encapsulated Zwitterionic Polymer-Lipid Micellar Nanoparticle for Enhanced Photothermal Therapy and NIR-Based Fluorescence Imaging in a Cervical Tumor Mouse Model.Int J Mol Sci. 2018 Apr 13;19(4):1189. doi: 10.3390/ijms19041189.
|
| 624 |
Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.Genes Chromosomes Cancer. 2009 Nov;48(11):983-92. doi: 10.1002/gcc.20703.
|
| 625 |
Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front.Am J Pathol. 2018 May;188(5):1276-1288. doi: 10.1016/j.ajpath.2018.01.016. Epub 2018 Feb 17.
|
| 626 |
Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation.Mol Oncol. 2019 Nov;13(11):2375-2392. doi: 10.1002/1878-0261.12565. Epub 2019 Oct 17.
|
| 627 |
Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China.PLoS One. 2017 Aug 2;12(8):e0182388. doi: 10.1371/journal.pone.0182388. eCollection 2017.
|
| 628 |
Genetic and Methylation-Induced Loss of miR-181a2/181b2 within chr9q33.3 Facilitates Tumor Growth of Cervical Cancer through the PIK3R3/Akt/FoxO Signaling Pathway.Clin Cancer Res. 2017 Jan 15;23(2):575-586. doi: 10.1158/1078-0432.CCR-16-0303. Epub 2016 Aug 8.
|
| 629 |
Differential expression of PIWIL2 in papillary thyroid cancers.Gene. 2018 Apr 5;649:8-13. doi: 10.1016/j.gene.2018.01.066. Epub 2018 Jan 31.
|
| 630 |
Resveratrol significantly inhibits the occurrence and development of cervical cancer by regulating phospholipid scramblase 1.J Cell Biochem. 2019 Feb;120(2):1527-1531. doi: 10.1002/jcb.27335. Epub 2018 Oct 22.
|
| 631 |
The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.Pathol Res Pract. 2019 May;215(5):1061-1065. doi: 10.1016/j.prp.2019.02.015. Epub 2019 Feb 27.
|
| 632 |
E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway.Sci Rep. 2017 Mar 17;7:44744. doi: 10.1038/srep44744.
|
| 633 |
Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.Oncogene. 2006 Aug 31;25(39):5436-45. doi: 10.1038/sj.onc.1209530. Epub 2006 Apr 10.
|
| 634 |
Molecular analysis of oncogenicity of the transcription factor, BRN3A, in cervical cancer cells.J Cancer Res Clin Oncol. 2011 Dec;137(12):1859-67. doi: 10.1007/s00432-011-1059-0. Epub 2011 Sep 18.
|
| 635 |
The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cancer Cell Lines.Med Sci Monit. 2019 Feb 14;25:1204-1213. doi: 10.12659/MSM.912109.
|
| 636 |
Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.Vaccine. 2018 Jul 5;36(29):4311-4316. doi: 10.1016/j.vaccine.2018.05.104. Epub 2018 Jun 5.
|
| 637 |
iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.J Exp Clin Cancer Res. 2017 Apr 11;36(1):48. doi: 10.1186/s13046-017-0520-6.
|
| 638 |
Arginine methyltransferase inhibitor 1 exhibits antitumor effects against cervical cancer in vitro and in vivo.Pharmazie. 2018 May 1;73(5):269-273. doi: 10.1691/ph.2018.8365.
|
| 639 |
Mutation analysis of the tumor suppressor gene PPP2R1B in human cervical cancer.Int J Gynecol Cancer. 2007 Jul-Aug;17(4):868-71. doi: 10.1111/j.1525-1438.2007.00880.x. Epub 2007 Mar 2.
|
| 640 |
Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers.Carcinogenesis. 2014 Nov;35(11):2611-8. doi: 10.1093/carcin/bgu197. Epub 2014 Sep 18.
|
| 641 |
Combination of RIZ1 Overexpression and Radiotherapy Contributes to Apoptosis and DNA Damage of HeLa and SiHa Cervical Cancer Cells.Basic Clin Pharmacol Toxicol. 2018 Aug;123(2):137-146. doi: 10.1111/bcpt.13008. Epub 2018 Apr 25.
|
| 642 |
PRMT8 demonstrates variant-specific expression in cancer cells and correlates with patient survival in breast, ovarian and gastric cancer.Oncol Lett. 2017 Mar;13(3):1983-1989. doi: 10.3892/ol.2017.5671. Epub 2017 Feb 1.
|
| 643 |
Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.J Womens Health (Larchmt). 2019 Aug;28(8):1094-1104. doi: 10.1089/jwh.2018.7141. Epub 2019 Mar 15.
|
| 644 |
TSP50 depends on its threonine protease activity and its interactions with TNF--induced NF-B for its role in human cervical tumorigenesis.Cell Biochem Biophys. 2015 Mar;71(2):891-6. doi: 10.1007/s12013-014-0279-8.
|
| 645 |
MiR-613 promotes cell proliferation and invasion in cervical cancer via targeting PTPN9.Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4107-4114. doi: 10.26355/eurrev_201807_15402.
|
| 646 |
The long non-coding RNA PTTG3P promotes growth and metastasis of cervical cancer through PTTG1.Aging (Albany NY). 2019 Mar 10;11(5):1333-1341. doi: 10.18632/aging.101830.
|
| 647 |
LncRNA TUG1 aggravates the progression of cervical cancer by binding PUM2.Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8211-8218. doi: 10.26355/eurrev_201910_19128.
|
| 648 |
The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer.Future Oncol. 2018 Feb;14(3):241-253. doi: 10.2217/fon-2017-0474. Epub 2018 Jan 10.
|
| 649 |
Inhibition of miR-574-5p suppresses cell growth and metastasis and enhances chemosensitivity by targeting RNA binding protein QKI in cervical cancer cells.Naunyn Schmiedebergs Arch Pharmacol. 2020 Jun;393(6):951-966. doi: 10.1007/s00210-019-01772-6. Epub 2019 Nov 30.
|
| 650 |
Hypoxia stimulates invasion and migration of human cervical cancer cell lines HeLa/SiHa through the Rab11 trafficking of integrin v3/FAK/PI3K pathway-mediated Rac1 activation.J Biosci. 2017 Sep;42(3):491-499. doi: 10.1007/s12038-017-9699-0.
|
| 651 |
TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.J Gene Med. 2019 Nov;21(11):e3125. doi: 10.1002/jgm.3125. Epub 2019 Nov 17.
|
| 652 |
Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.Exp Cell Res. 2019 May 15;378(2):139-148. doi: 10.1016/j.yexcr.2019.02.025. Epub 2019 Feb 28.
|
| 653 |
The effect of aberrant expression and genetic polymorphisms of Rad21 on cervical cancer biology.Cancer Med. 2018 Jul;7(7):3393-3405. doi: 10.1002/cam4.1592. Epub 2018 May 24.
|
| 654 |
DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system.Eur J Pharm Biopharm. 2018 Jun;127:288-297. doi: 10.1016/j.ejpb.2018.02.029. Epub 2018 Mar 3.
|
| 655 |
Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells.Cancer Biomark. 2019;24(3):257-267. doi: 10.3233/CBM-181225.
|
| 656 |
Knockdown of Rap2B, a Ras Superfamily Protein, Inhibits Proliferation, Migration, and Invasion in Cervical Cancer Cells via Regulating the ERK1/2 Signaling Pathway.Oncol Res. 2018 Jan 19;26(1):123-130. doi: 10.3727/096504017X14912172235777. Epub 2017 Apr 3.
|
| 657 |
RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.Arch Gynecol Obstet. 2018 Feb;297(2):467-477. doi: 10.1007/s00404-017-4639-7. Epub 2017 Dec 29.
|
| 658 |
RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.Mod Pathol. 2013 Aug;26(8):1111-22. doi: 10.1038/modpathol.2013.32. Epub 2013 Mar 29.
|
| 659 |
Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8.PLoS One. 2016 Sep 14;11(9):e0162378. doi: 10.1371/journal.pone.0162378. eCollection 2016.
|
| 660 |
Involvement of retinoblastoma-associated protein48 during photodynamic therapy of cervical cancer cells.Mol Med Rep. 2017 Mar;15(3):1393-1400. doi: 10.3892/mmr.2017.6151. Epub 2017 Jan 26.
|
| 661 |
RBBP6 promotes human cervical carcinoma malignancy via JNK signaling pathway.Biomed Pharmacother. 2018 May;101:399-405. doi: 10.1016/j.biopha.2018.02.083. Epub 2018 Mar 22.
|
| 662 |
Enhanced specificity of the p53 family proteins-based adenoviral gene therapy in uterine cervical cancer cells with E2F1-responsive promoters.Cancer Biol Ther. 2006 Nov;5(11):1502-10. doi: 10.4161/cbt.5.11.3300. Epub 2006 Nov 19.
|
| 663 |
Effects of RECQ1 helicase silencing on non-small cell lung cancer cells.Biomed Pharmacother. 2016 Oct;83:1227-1232. doi: 10.1016/j.biopha.2016.07.053. Epub 2016 Aug 23.
|
| 664 |
Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis.PLoS One. 2013 Jul 17;8(7):e69607. doi: 10.1371/journal.pone.0069607. Print 2013.
|
| 665 |
Synthesis and Anticancer Activity Evaluation of Hydrolyzed Derivatives of Panaxnotoginseng Saponins.Molecules. 2018 Nov 19;23(11):3021. doi: 10.3390/molecules23113021.
|
| 666 |
REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells.PLoS One. 2015 Mar 17;10(3):e0120334. doi: 10.1371/journal.pone.0120334. eCollection 2015.
|
| 667 |
Systematic identification of key genes and pathways in the development of invasive cervical cancer.Gene. 2017 Jun 30;618:28-41. doi: 10.1016/j.gene.2017.03.018. Epub 2017 Mar 21.
|
| 668 |
LincRNA-p21 knockdown enhances radiosensitivity of hypoxic tumor cells by reducing autophagy through HIF-1/Akt/mTOR/P70S6K pathway.Exp Cell Res. 2017 Sep 15;358(2):188-198. doi: 10.1016/j.yexcr.2017.06.016. Epub 2017 Jul 8.
|
| 669 |
RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/-catenin signaling.Cell Death Dis. 2018 Sep 20;9(10):942. doi: 10.1038/s41419-018-0972-4.
|
| 670 |
RITA enhances irradiation-induced apoptosis in p53-defective cervical cancer cells via upregulation of IRE1/XBP1 signaling.Oncol Rep. 2015 Sep;34(3):1279-88. doi: 10.3892/or.2015.4083. Epub 2015 Jun 25.
|
| 671 |
EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition.Hum Pathol. 2014 Feb;45(2):372-81. doi: 10.1016/j.humpath.2013.10.001. Epub 2013 Oct 18.
|
| 672 |
p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis.Cell Cycle. 2017 Sep 17;16(18):1673-1682. doi: 10.1080/15384101.2017.1320629. Epub 2017 Aug 25.
|
| 673 |
Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.Biosci Rep. 2019 May 7;39(5):BSR20181815. doi: 10.1042/BSR20181815. Print 2019 May 31.
|
| 674 |
Limited Role of Promoter Methylation of MGMT and C13ORF18 in Triage of Low-Grade Squamous Intraepithelial Lesion.Chin Med J (Engl). 2018 Apr 20;131(8):939-944. doi: 10.4103/0366-6999.229896.
|
| 675 |
S100 Calcium Binding Protein A11 (S100A11) Promotes The Proliferation, Migration And Invasion Of Cervical Cancer Cells, And Activates Wnt/-Catenin Signaling.Onco Targets Ther. 2019 Oct 22;12:8675-8685. doi: 10.2147/OTT.S225248. eCollection 2019.
|
| 676 |
S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition.Oncotarget. 2017 Apr 11;8(15):24964-24977. doi: 10.18632/oncotarget.15329.
|
| 677 |
Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.PLoS One. 2015 Dec 23;10(12):e0145700. doi: 10.1371/journal.pone.0145700. eCollection 2015.
|
| 678 |
Downregulation of SASH1 correlates with poor prognosis in cervical cancer.Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3781-3786.
|
| 679 |
Prospective comparison of hybrid capture 2 and SPF-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.J Gynecol Oncol. 2017 Sep;28(5):e66. doi: 10.3802/jgo.2017.28.e66. Epub 2017 Jun 5.
|
| 680 |
Sec62/Ki67 dual staining in cervical cytology specimens: a new marker for high-grade dysplasia.Arch Gynecol Obstet. 2019 Feb;299(2):481-488. doi: 10.1007/s00404-018-4981-4. Epub 2018 Nov 29.
|
| 681 |
SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis.Front Oncol. 2019 Oct 9;9:1035. doi: 10.3389/fonc.2019.01035. eCollection 2019.
|
| 682 |
The association of semaphorin 5A with lymph node metastasis and adverse prognosis in cervical cancer.Cancer Cell Int. 2018 Jun 22;18:87. doi: 10.1186/s12935-018-0584-1. eCollection 2018.
|
| 683 |
Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.Br J Cancer. 2018 Jan;118(1):72-78. doi: 10.1038/bjc.2017.390. Epub 2017 Nov 7.
|
| 684 |
MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.Oncotarget. 2016 Jul 19;7(29):45622-45636. doi: 10.18632/oncotarget.9850.
|
| 685 |
SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.Gynecol Oncol. 2009 Mar;112(3):646-53. doi: 10.1016/j.ygyno.2008.10.026. Epub 2008 Dec 18.
|
| 686 |
SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin.J Cell Biochem. 2018 Feb;119(2):1733-1745. doi: 10.1002/jcb.26334. Epub 2017 Sep 18.
|
| 687 |
Expression of sex hormone-binding globulin exon 7 splicing variant mRNA in secondary spreading lesions of gynecological cancers.J Steroid Biochem Mol Biol. 1999 Feb;68(3-4):103-9. doi: 10.1016/s0960-0760(99)00025-4.
|
| 688 |
Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.Diagn Cytopathol. 2018 Jan;46(1):15-21. doi: 10.1002/dc.23838. Epub 2017 Oct 24.
|
| 689 |
Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.Tumour Biol. 2015 Aug;36(8):6159-71. doi: 10.1007/s13277-015-3300-y. Epub 2015 Mar 21.
|
| 690 |
SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway.Cancer Cell Int. 2018 Nov 14;18:183. doi: 10.1186/s12935-018-0670-4. eCollection 2018.
|
| 691 |
Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.Cancer Res. 2009 Jul 15;69(14):5656-63. doi: 10.1158/0008-5472.CAN-08-3711. Epub 2009 Jul 7.
|
| 692 |
SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm.Gynecol Oncol. 2018 Mar;148(3):456-460. doi: 10.1016/j.ygyno.2018.01.001. Epub 2018 Feb 1.
|
| 693 |
The SMC5/6 Complex Interacts with the Papillomavirus E2 Protein and Influences Maintenance of Viral Episomal DNA.J Virol. 2018 Jul 17;92(15):e00356-18. doi: 10.1128/JVI.00356-18. Print 2018 Aug 1.
|
| 694 |
Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?.Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1551-1559. doi: 10.1007/s00259-018-4219-5. Epub 2019 Feb 7.
|
| 695 |
SNAP23 suppresses cervical cancer progression via modulating the cell cycle.Gene. 2018 Oct 5;673:217-224. doi: 10.1016/j.gene.2018.06.028. Epub 2018 Jun 23.
|
| 696 |
miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.Oncol Lett. 2018 Mar;15(3):3075-3080. doi: 10.3892/ol.2017.7651. Epub 2017 Dec 19.
|
| 697 |
Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.Oncotarget. 2016 Dec 6;7(49):80735-80750. doi: 10.18632/oncotarget.12598.
|
| 698 |
GWAS of five gynecologic diseases and cross-trait analysis in Japanese.Eur J Hum Genet. 2020 Jan;28(1):95-107. doi: 10.1038/s41431-019-0495-1. Epub 2019 Sep 5.
|
| 699 |
MicroRNA-367-3p overexpression represses the proliferation and invasion of cervical cancer cells through downregulation of SPAG5-mediated Wnt/-catenin signalling.Clin Exp Pharmacol Physiol. 2020 Apr;47(4):687-695. doi: 10.1111/1440-1681.13222. Epub 2020 Jan 19.
|
| 700 |
Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth.Cancer. 2009 Dec 15;115(24):5688-99. doi: 10.1002/cncr.24658.
|
| 701 |
Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.Cancer Biomark. 2018 Feb 6;21(2):355-365. doi: 10.3233/CBM-170501.
|
| 702 |
Study on the methylation status of SPINT2 gene and its expression in cervical carcinoma.Cancer Biomark. 2018;22(3):435-442. doi: 10.3233/CBM-171050.
|
| 703 |
Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis.Biosci Rep. 2019 Jun 4;39(6):BSR20181339. doi: 10.1042/BSR20181339. Print 2019 Jun 28.
|
| 704 |
Suppressing serum response factor inhibits invasion in cervical cancer cell lines via regulating Egr? and epithelial-mesenchymal transition.Int J Mol Med. 2019 Jan;43(1):614-620. doi: 10.3892/ijmm.2018.3954. Epub 2018 Oct 24.
|
| 705 |
Long non-coding RNA MIR205HG regulates KRT17 and tumor processes in cervical cancer via interaction with SRSF1.Exp Mol Pathol. 2019 Dec;111:104322. doi: 10.1016/j.yexmp.2019.104322. Epub 2019 Oct 23.
|
| 706 |
microRNA-802 inhibits cell proliferation and induces apoptosis in human cervical cancer by targeting serine/arginine-rich splicing factor 9.J Cell Biochem. 2019 Jun;120(6):10370-10379. doi: 10.1002/jcb.28321. Epub 2018 Dec 19.
|
| 707 |
Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.BMC Cancer. 2016 Dec 16;16(1):949. doi: 10.1186/s12885-016-2981-y.
|
| 708 |
Suppression of stromal interaction molecule 1 inhibits SMMC7721 hepatocellular carcinoma cell proliferation by inducing cell cycle arrest.Biotechnol Appl Biochem. 2015 Jan-Feb;62(1):107-11. doi: 10.1002/bab.1245. Epub 2014 Dec 15.
|
| 709 |
Interaction between susceptibility loci in cGAS-STING pathway, MHC gene and HPV infection on the risk of cervical precancerous lesions in Chinese population.Oncotarget. 2016 Dec 20;7(51):84228-84238. doi: 10.18632/oncotarget.12399.
|
| 710 |
Stomatin-like protein 2 expression is associated with clinical survival in patients with cervical cancer.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1804-9. eCollection 2015.
|
| 711 |
TMC-SNPdb: an Indian germline variant database derived from whole exome sequences.Database (Oxford). 2016 Jul 9;2016:baw104. doi: 10.1093/database/baw104. Print 2016.
|
| 712 |
Bridging Links between Long Noncoding RNA HOTAIR and HPV Oncoprotein E7 in Cervical Cancer Pathogenesis.Sci Rep. 2015 Jul 8;5:11724. doi: 10.1038/srep11724.
|
| 713 |
Synaptonemal complex protein 3 is a prognostic marker in cervical cancer.PLoS One. 2014 Jun 6;9(6):e98712. doi: 10.1371/journal.pone.0098712. eCollection 2014.
|
| 714 |
An update meta-analysis and systematic review of TAP polymorphisms as potential biomarkers for judging cancer risk.Pathol Res Pract. 2018 Oct;214(10):1556-1563. doi: 10.1016/j.prp.2018.07.018. Epub 2018 Jul 29.
|
| 715 |
Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.Int J Nanomedicine. 2017 Jan 31;12:955-968. doi: 10.2147/IJN.S115136. eCollection 2017.
|
| 716 |
Cervical cancer stem-like cells: systematic review and identification of reference genes for gene expression.Cell Biol Int. 2018 Feb;42(2):139-152. doi: 10.1002/cbin.10878. Epub 2017 Nov 9.
|
| 717 |
LncRNATCF7 up-regulates DNMT1 mediated by HPV-18 E6 and regulates biological behavior of cervical cancer cells by inhibiting miR-155.Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8779-8787. doi: 10.26355/eurrev_201910_19272.
|
| 718 |
HOTAIR Knockdown Decreased the Activity Wnt/-Catenin Signaling Pathway and Increased the mRNA Levels of Its Negative Regulators in Hela Cells.Cell Physiol Biochem. 2019;53(6):948-960. doi: 10.33594/000000188.
|
| 719 |
Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1844-54. eCollection 2015.
|
| 720 |
MicroRNA-20a regulates cell proliferation, apoptosis and autophagy by targeting thrombospondin 2 in cervical cancer.Eur J Pharmacol. 2019 Feb 5;844:102-109. doi: 10.1016/j.ejphar.2018.11.043. Epub 2018 Dec 1.
|
| 721 |
HPV16(+) -miRNAs in cervical cancer and the anti-tumor role played by miR-5701.J Gene Med. 2019 Nov;21(11):e3126. doi: 10.1002/jgm.3126. Epub 2019 Oct 25.
|
| 722 |
Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.Int J Oncol. 2017 Jan;50(1):173-184. doi: 10.3892/ijo.2016.3784. Epub 2016 Nov 29.
|
| 723 |
Low expression of TUG1 promotes cisplatin sensitivity in cervical cancer by activating the MAPK pathway.J BUON. 2019 May-Jun;24(3):1020-1026.
|
| 724 |
MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.Oncol Rep. 2017 Sep;38(3):1774-1782. doi: 10.3892/or.2017.5832. Epub 2017 Jul 18.
|
| 725 |
Genetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control study.BMC Cancer. 2016 Nov 29;16(1):923. doi: 10.1186/s12885-016-2960-3.
|
| 726 |
Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.Cancer Causes Control. 2016 Jun;27(6):809-15. doi: 10.1007/s10552-016-0749-y. Epub 2016 Apr 20.
|
| 727 |
TNFAIP8 promotes cisplatin resistance in cervical carcinoma cells by inhibiting cellular apoptosis.Oncol Lett. 2019 May;17(5):4667-4674. doi: 10.3892/ol.2019.10076. Epub 2019 Feb 26.
|
| 728 |
TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome.Carcinogenesis. 2019 Jun 10;40(4):592-599. doi: 10.1093/carcin/bgy163.
|
| 729 |
Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.Genes Chromosomes Cancer. 2016 Feb;55(2):177-89. doi: 10.1002/gcc.22325. Epub 2015 Nov 6.
|
| 730 |
Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.Pathol Res Pract. 2019 May;215(5):939-945. doi: 10.1016/j.prp.2019.01.044. Epub 2019 Jan 30.
|
| 731 |
MicroRNA-15a-5p down-regulation inhibits cervical cancer by targeting TP53INP1 in vitro.Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8219-8229. doi: 10.26355/eurrev_201910_19129.
|
| 732 |
Association Study Between Methylation in the Promoter Regions of cGAS, MAVS, and TRAF3 Genes and the Risk of Cervical Precancerous Lesions and Cervical Cancer in a Southern Chinese Population.Front Genet. 2019 Nov 14;10:1123. doi: 10.3389/fgene.2019.01123. eCollection 2019.
|
| 733 |
TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/-catenin pathway in cervical cancer.Oncotarget. 2016 May 10;7(19):28579-91. doi: 10.18632/oncotarget.8686.
|
| 734 |
miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.Biochem Biophys Res Commun. 2019 Aug 27;516(3):872-879. doi: 10.1016/j.bbrc.2019.06.126. Epub 2019 Jun 30.
|
| 735 |
High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.Biosci Rep. 2019 Mar 6;39(3):BSR20181639. doi: 10.1042/BSR20181639. Print 2019 Mar 29.
|
| 736 |
Knockdown of Trio by CRISPR/Cas9 suppresses migration and invasion of cervical cancer cells.Oncol Rep. 2018 Feb;39(2):795-801. doi: 10.3892/or.2017.6117. Epub 2017 Nov 28.
|
| 737 |
TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.Cancer Lett. 2019 Jun 28;452:1-13. doi: 10.1016/j.canlet.2019.03.017. Epub 2019 Mar 21.
|
| 738 |
TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer.Oncotarget. 2017 Aug 16;8(58):97990-98003. doi: 10.18632/oncotarget.20296. eCollection 2017 Nov 17.
|
| 739 |
Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo.Cancer Gene Ther. 2013 Jul;20(7):413-20. doi: 10.1038/cgt.2013.32. Epub 2013 Jun 14.
|
| 740 |
Increased migration and local invasion potential of SiHa cervical cancer cells expressing Aquaporin 8.Asian Pac J Cancer Prev. 2013;14(3):1825-8. doi: 10.7314/apjcp.2013.14.3.1825.
|
| 741 |
Inhibition of ADP-ribosylation factor-like 6 interacting protein 1 suppresses proliferation and reduces tumor cell invasion in CaSki human cervical cancer cells.Mol Biol Rep. 2010 Dec;37(8):3819-25. doi: 10.1007/s11033-010-0037-y. Epub 2010 Mar 7.
|
| 742 |
Human papillomavirus infection and expression of ATPase family AAA domain containing 3A, a novel anti-autophagy factor, in uterine cervical cancer.Int J Mol Med. 2011 Nov;28(5):689-96. doi: 10.3892/ijmm.2011.743. Epub 2011 Jul 8.
|
| 743 |
Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-B-dependent cyclin D1 signaling.Gynecol Oncol. 2012 Aug;126(2):245-51. doi: 10.1016/j.ygyno.2012.04.047. Epub 2012 May 4.
|
| 744 |
Folate and choline metabolism gene variants and development of uterine cervical carcinoma.Clin Biochem. 2011 Jun;44(8-9):596-600. doi: 10.1016/j.clinbiochem.2011.02.007. Epub 2011 Feb 22.
|
| 745 |
Sperm protein 17 is highly expressed in endometrial and cervical cancers.BMC Cancer. 2010 Aug 16;10:429. doi: 10.1186/1471-2407-10-429.
|
| 746 |
Association between the CDC6 G1321A polymorphism and the risk of cervical cancer.Int J Gynecol Cancer. 2010 Jul;20(5):856-61. doi: 10.1111/IGC.0b013e3181df3cab.
|
| 747 |
Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer.Mol Cancer Res. 2013 Jan;11(1):19-30. doi: 10.1158/1541-7786.MCR-12-0510. Epub 2013 Jan 2.
|
| 748 |
A single nucleotide polymorphism in EXO1 gene is associated with cervical cancer susceptibility in Chinese patients.Int J Gynecol Cancer. 2012 Feb;22(2):220-5. doi: 10.1097/IGC.0b013e318234fd8a.
|
| 749 |
MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl--D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.J Biol Chem. 2012 Apr 20;287(17):14301-9. doi: 10.1074/jbc.M111.337642. Epub 2012 Mar 7.
|
| 750 |
Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis.Int J Clin Exp Pathol. 2013;6(4):669-77. Epub 2013 Mar 15.
|
| 751 |
The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.J Biol Chem. 2013 Dec 13;288(50):35637-50. doi: 10.1074/jbc.M113.472076. Epub 2013 Oct 25.
|
| 752 |
Helicase-like transcription factor confers radiation resistance in cervical cancer through enhancing the DNA damage repair capacity.J Cancer Res Clin Oncol. 2011 Apr;137(4):629-37. doi: 10.1007/s00432-010-0925-5. Epub 2010 Jun 10.
|
| 753 |
MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.PLoS One. 2013 Jul 4;8(7):e67846. doi: 10.1371/journal.pone.0067846. Print 2013.
|
| 754 |
The immunoexpression of heparanase 2 in normal epithelium, intraepithelial, and invasive squamous neoplasia of the cervix.J Low Genit Tract Dis. 2012 Jul;16(3):256-62. doi: 10.1097/LGT.0b013e3182422c69.
|
| 755 |
Genetic polymorphisms in the ITPKC gene and cervical squamous cell carcinoma risk.Cancer Immunol Immunother. 2012 Nov;61(11):2153-9. doi: 10.1007/s00262-012-1280-y. Epub 2012 May 18.
|
| 756 |
A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.Cancer Res. 2011 Nov 1;71(21):6696-707. doi: 10.1158/0008-5472.CAN-11-1271. Epub 2011 Sep 9.
|
| 757 |
Loss of LDOC1 expression by promoter methylation in cervical cancer cells.Cancer Invest. 2013 Nov;31(9):571-7. doi: 10.3109/07357907.2013.845671. Epub 2013 Oct 14.
|
| 758 |
Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells.Mol Cancer. 2010 Jan 28;9:20. doi: 10.1186/1476-4598-9-20.
|
| 759 |
The association between -1304T>G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and the risk of cervical cancer in Chinese population.DNA Cell Biol. 2012 Jul;31(7):1167-73. doi: 10.1089/dna.2011.1586. Epub 2012 Feb 15.
|
| 760 |
The MBD4 Glu346Lys polymorphism is associated with the risk of cervical cancer in a Chinese population.Int J Gynecol Cancer. 2012 Nov;22(9):1552-6. doi: 10.1097/IGC.0b013e31826e22e4.
|
| 761 |
Cytoplasmic NANOG-positive stromal cells promote human cervical cancer progression.Am J Pathol. 2012 Aug;181(2):652-61. doi: 10.1016/j.ajpath.2012.04.008. Epub 2012 Jun 6.
|
| 762 |
Comparison of diversity of torque teno virus 1 in different mucosal tissues and disorders.Acta Microbiol Immunol Hung. 2011 Dec;58(4):319-37. doi: 10.1556/AMicr.58.2011.4.8.
|
| 763 |
HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells.Exp Cell Res. 2010 Jul 15;316(12):1985-93. doi: 10.1016/j.yexcr.2010.02.028. Epub 2010 Mar 3.
|
| 764 |
Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.Gynecol Oncol. 2012 Jan;124(1):112-8. doi: 10.1016/j.ygyno.2011.09.003. Epub 2011 Oct 22.
|
| 765 |
Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy.Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1144-52. doi: 10.1016/j.ijrobp.2010.09.012. Epub 2010 Nov 2.
|
| 766 |
Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer.Biomarkers. 2013 Nov;18(7):573-9. doi: 10.3109/1354750X.2013.827742. Epub 2013 Aug 19.
|
| 767 |
PIWIL4 regulates cervical cancer cell line growth and is involved in down-regulating the expression of p14ARF and p53.FEBS Lett. 2012 May 7;586(9):1356-62. doi: 10.1016/j.febslet.2012.03.053. Epub 2012 Mar 31.
|
| 768 |
Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells.Int J Biochem Cell Biol. 2011 Apr;43(4):632-41. doi: 10.1016/j.biocel.2011.01.002. Epub 2011 Jan 7.
|
| 769 |
Identification of human patatin-like phospholipase domain-containing protein 1 and a mutant in human cervical cancer HeLa cells.Mol Biol Rep. 2013 Oct;40(10):5597-605. doi: 10.1007/s11033-013-2661-9. Epub 2013 Sep 22.
|
| 770 |
DNA methylation and carcinogenesis of PRDM5 in cervical cancer.J Cancer Res Clin Oncol. 2010 Dec;136(12):1821-5. doi: 10.1007/s00432-010-0840-9. Epub 2010 Mar 6.
|
| 771 |
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.PLoS One. 2012;7(4):e33619. doi: 10.1371/journal.pone.0033619. Epub 2012 Apr 9.
|
| 772 |
Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer.J Cancer Res Clin Oncol. 2013 Feb;139(2):259-67. doi: 10.1007/s00432-012-1317-9. Epub 2012 Oct 9.
|
| 773 |
RAD52 variants predict platinum resistance and prognosis of cervical cancer.PLoS One. 2012;7(11):e50461. doi: 10.1371/journal.pone.0050461. Epub 2012 Nov 29.
|
| 774 |
Cellular retinol binding protein 1 could be a tumor suppressor gene in cervical cancer.Int J Clin Exp Pathol. 2013 Aug 15;6(9):1817-25. eCollection 2013.
|
| 775 |
Identification of the deleted in split hand/split foot 1 protein as a novel biomarker for human cervical cancer.Carcinogenesis. 2013 Jan;34(1):68-78. doi: 10.1093/carcin/bgs279. Epub 2012 Sep 28.
|
| 776 |
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.J Clin Invest. 2010 Jun;120(6):2094-108. doi: 10.1172/JCI40778. Epub 2010 May 10.
|
| 777 |
miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/-catenin pathway in cervical cancer.Int J Mol Med. 2017 Oct;40(4):1047-1056. doi: 10.3892/ijmm.2017.3116. Epub 2017 Aug 30.
|
| 778 |
SZRD1 is a Novel Protein that Functions as a Potential Tumor Suppressor in Cervical Cancer.J Cancer. 2017 Jul 14;8(11):2132-2141. doi: 10.7150/jca.18806. eCollection 2017.
|
| 779 |
Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors.Cancer Res. 2009 May 15;69(10):4319-26. doi: 10.1158/0008-5472.CAN-08-3141. Epub 2009 May 12.
|
|
|
|
|
|
|
